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ABSTRACT
Gold nanoparticles (AuNPs) have attracted enormous attention in the field of
nanotechnology for applications such as, immunoassay, drug delivery, contrast
enhancement and tumor therapy. The typical range of gold nanoparticles varies from 1–
150 nm; there are many different subtypes of AuNPs mainly based on size, shape, and
optical properties including: gold nanospheres, nanorods, nanocages, and nanoshells. The
main advantage of using gold nanoparticles is the large surface-to-volume ratio; this will
allow the particles to be functionalized with drugs and/or targeting agents to create many
novel applications. Many AuNPs have another advantage as well, they can be fabricated
to either absorb or scatter light in the visible to near-infrared (nIR) region of the
spectrum. Current research, using gold nanoparticles, mainly focuses on taking advantage
of the nIR window. In biomedical research the nIR window is very important; nIR light
has minimal interference with tissue and only affects samples which absorb nIR light,
which enables minimally invasive imaging and treatment.
Specifically, gold/gold sulfide nanoparticles (GGS) have been introduced for
many applications compared to silica-gold nanoshells due to the smaller size of particles.
This project is focused on a novel purification/high yield process of GGS nanoparticles
using chloroauric acid (HAuCl4) and sodium thiosulfate (Na2S2O3), with desired nIR
peak that can be used for therapeutic applications. By combining the traditional published
methods for 1-step self-assembly of GGS nanoparticles and dialysis techniques
simultaneously, a new method for production of gold / gold-sulfide nanoparticles has
been established in this research project which we call DiaSynth. In this process the
equilibrium of the reaction is shifted to favor the formation of nIR absorbing particles.
2

This technique minimizes production of gold nanoparticles with 530 nm resonance
(colloidal gold), resulting in populations of nanoparticles that require minimum further
processing for use as a therapeutic agent. The colloidal gold is considered a contaminant,
formed during the self-assembly process, which are traditionally removed via multi-step
centrifugation. We define a ratio of the absorbance of peaks, RnIR/Au ; this is based on the
peak absorbance in of the nIR region (700 – 900 nm) relative to the colloidal gold peak
(~530 nm) as a relative measure of the quality of nIR particles. The current method for
producing nIR GGS, based on a single step procedure, results in a poor ratio, RnIR/Au =
0.7 – 1.0. The DiaSynth method utilizes a shift in kinetics via removal of smaller ions and
other products during the reduction of gold and sulfur. This method has allowed us to
increase the yield of as made product to have an RnIR/Au = 1.7 – 2.0. In comparison,
purification by centrifugation results in great loss of particles during each step to achieve
similar ratios. At a ratio of 1.7 – 2.36, no centrifugation is needed to separate out
colloidal gold, resulting in reduced production costs and higher quality product.
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CHAPTER 1 – Gold Nanoparticles
1.1

INTRODUCTION

Gold nanoparticles
Biomedicine, involving the study of processes in biology, chemistry, and physics,
has been one of the cores in nanotechnology (W. Cai 2008). Gold nanoparticles vary in
size, typically in the range of 1–150 nm (Azzazy and Mansour 2009). However, there are
many different subtypes of AuNPs based on their size, shape, and properties including:
gold nanospheres, nanorods, nanocages, and nanoshells (W. Cai 2008). One important
property of these nanoparticles is a large surface-to-volume ratio, though most of the
nanoparticles have the size range of biomolecules and cellular organelles; not only does
this give a possibility of interaction between the gold nanoparticles and biomolecules, but
opens the field to various medical applications (Azzazy and Mansour 2009).
Nanoparticles can specifically be tuned as nano-platforms for an effective and
targeted delivery of drugs, and imaging labels by reducing many biological, biophysical,
and biomedical limitations for many application in vitro and ex vivo (W. Cai 2008). Due
to the versatile properties gold nanoparticles (AuNPs), they have been introduced in the
field of biomedical applications for drug delivery, ex/in-vivo imaging, in-vitro assays,
and cancer therapy (theranostic applications) (W. Cai 2008). For many biological
applications, gold nanoparticles must be conjugated with assorted biospecific recognition
molecules, including antibodies, DNA probe molecules, biotin, and enzymes (Azzazy and
Mansour 2009; Xie, Gao et al. 2009). By using different stabilizing molecules/agents
gold nanoparticle properties can be altered. These biospecific molecules can be replaced
15

by other macromolecules; not only can the surface of gold nanoparticles be modified
either by coating or by grafting a macromolecule, but the properties of nanoparticles can
be changed such as adsorption, size, zeta potential (charge), and hydrophobicity
(Agbenyega 2008; Rai 2011).
Most of these applications are based on the advantage of using the unique optical
properties of gold, such as surface plasmon resonance (SPR), luminescence, surfaceenhanced Raman scattering, catalytic effect, and amplification effect (Azzazy and
Mansour 2009; Xie, Gao et al. 2009). In order to attach or coat the surface of gold
nanoparticles with biospecific molecules, they are usually connected with ligands.
Alkanethiols are the most common self-assembled monolayer (SAMs) used for
passivating gold nanoparticles (Huo 2007; Rai 2011). Gold nanoparticles have been used
as contrast agent for scanning electron and light microscopy in histology; they also have
played an important role in advancing biosensor performance due to their large effective
surface area and excellent biocompatibility (Huo 2007; Rai 2011).
AuNPs has been used in stained glass windows for centuries. However, recently,
in the last decade or so, researchers have begun to understand the fundamental concepts
that not only explain the optical properties at the nanoscale, but how these particles can
be used in many different applications (Stone, Jackson et al. 2011). AuNPs can be
fabricated to either absorb or scatter light in the visible to near-infrared (nIR) region of
the spectrum (Lowery, Gobin et al. 2006; Gobin, Lee et al. 2007; Day, Bickford et al.
2010; Gobin, Watkins et al. 2010; Stone, Jackson et al. 2011). These unique optical
properties are a result from the oscillations of electrons along the metal surface, which
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can be changed by modifying the particles’ shape, size, or the medium that particles are
suspended in (Pérez-Juste, Pastoriza-Santos et al. 2005; Stone, Jackson et al. 2011).
1.2

Applications
Theranostic applications have emerged as a technique to combine diagnosis,

treatment, and imaging in cancer research, thus not only decreasing time, but improving
efficacy of therapy. The ideal theranostic approach for cancer therapy has several tunable
factors, which can range from imaging to treatment with a display of specifically
targeting cancer cells (Young, Figueroa et al. 2012). Researchers have now begun to
introduce multimodal nanoparticles for therapeutic and imaging contrast applications
(Ren and Chow 2003; Park, Yang et al. 2008; Jelveh and Chithrani 2011; Sun, Eun et al.
2011). Specifically, gold/gold sulfide nanoparticles (GGS) has been developed for many
of the same applications compared to silica-gold nanoshells because of the smaller size,
higher absorptive properties, and easier to fabricate using the single-step self-assembly
process described in the later parts of the chapter. (Gobin, Watkins et al. 2010). The
theranostic effects of GGS are the result of surface plasmon oscillations to convert light
into heat, causing increase in local temperature to ablate the specifically targeted cells,
which occurs using frequency of light that matches the absorptive properties of GGS
(Vladimir P. Zharov 2003; Song, Risco et al. 2008; Ghosh, Dutta et al. 2009; Lapotko
2011; Lukianova-Hleb, Koneva et al. 2011; Melancon, Zhou et al. 2011).
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1.2.1

Nanoshells
Gold nanoshells (GNS) are tunable spherical nanoparticles, composed of a

dielectric core covered by a thin gold shell, with diameters ranging from 10 to 200 nm
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Figure 1: Spectral profile (A) image of the GNS that were fabricated with radius
of ~74 nm and core of ~60 nm and STEM image (B) to confirm the synthesis.
(Erickson and Tunnell 2007). (Figure1) GNS have optical, chemical and physical
properties, which make them an ideal candidate for enhancing cancer detection, cancer
treatment, cellular imaging, and medical biosensing. Furthermore, gold affinity for thiol
group with biocompatibility and it also simplifies conjugation to monoclonal antibodies
or other biomolecules for both active tumor targeting and biosensing applications.
Nanoshells can be fabricated with tunable optical properties, absorbing or scattering,
from visible to infrared spectrum.
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GNS, due to their unique physical characteristics and benign toxicity profile, have
been using in number of biomedical applications (Erickson and Tunnell 2007); however,
they have shown the greatest potential for cancer targeting, imaging, and therapy agents.
The use of GNS in contrast agents has been utilized to detect and image individual cancer
cells in vitro and in vivo (Lowery, Gobin et al. 2006; Erickson and Tunnell 2007; Gobin,
Lee et al. 2007). As a photothermal agent, GNS have successfully shown, in animal
studies, to induce thermal necrosis of tumors. As biosensors, GNS have been used for the
sensitive detection of biomarkers at the ng/ml concentrations (Hirsch, Jackson et al. 2003;
Erickson and Tunnell 2007).
1.2.2

Nanorods
AuNPs having a “rod-like” structure has been in interest due to their unique

shape. The spectral profile of the gold nanorods includes two specific bands: one due to
light absorbed along the short axis (~530 nm) and the other due to absorption along the
long axis (~650-1000 nm) (Stone, Jackson et al. 2011). As the length of the nanorod
increases, there is a red band shift, and because of this optical “control gold nanorods can
be used for sensing, photothermal therapy, and imaging (Pérez-Juste, Pastoriza-Santos et
al. 2005; Stone, Jackson et al. 2011).
The correlation between gold nanorod size, charge, shape, and spectral profile as
a result of changes in dielectric and interparticle spacing, makes them acceptable as
sensors (Yu and Irudayaraj 2006; Stone, Jackson et al. 2011). Yu and Irudayaraj et al.
demonstrated a multiplex sensing system using gold nanorods with three different
targeted IgGs. Yu and Irudayaraj et al. were able to measure the specificity and
sensitivity caused by interactions between the IgGs and gold nanorods (Yu and Irudayaraj
19

2006). This approach can be used in the development of optical biosensors for both in
vivo and in vitro detection. However, Huang et al. demonstrated the potential usage of
gold nanorods as a dual agent, molecular imaging and photothermal ablation therapy of
cancer cells using a near-infrared laser. Hunag et al, conjugated anti-epidermal growth
factor receptor (anti-EGFR) antibodies to the surface of gold nanorods to be used as for
targeting (Huang, El-Sayed et al. 2006).
1.2.3

Nanocages
Gold nanocages represent a class of gold nanostructures with hollow interiors and

porous walls (Chen, McLellan et al. 2006; Yavuz, Cheng et al. 2009). Gold nanocages
has a strong absorption in the near-infrared region (Yavuz, Cheng et al. 2009). As
mentioned by Yauvz et al., when the surface of a gold nanocage is covered with a
“smart polymer”, using a near-infrared laser to heat the polymer or the surface of the
nanocage allows the release of a drug. Xai et al. functionalized the surface of gold
nanocages with thermally responsive polymer, poly(Nisopropylacrylamide) (pNIPAAm)
with a gold thiolate bonding, to control the release of a drug using near-infrared laser
irradiation (Xia, Li et al. 2011). The pNIPAAm polymer chain has the ability to change
conformation in response to temperature variation, and can be modified using different
amounts of acrylamide. Once the gold nanocages undergo laser irradiation, the light is
absorbed and converted into heat. Next, the polymer chains will collapse as the
temperature increase, which ultimately leads to the opening of pores and thus releasing
the drugs (Yavuz, Cheng et al. 2009; Xia, Li et al. 2011).
Chen et al. evaluated the use of PEGylated Au nanocages with passive targeting
capabilities in a tumor mouse model (Chen, McLellan et al. 2006). The passive targeting
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depends on the aggregation of the nanoparticles in a tumor through leaky vasculature.
However, active targeting, the second type of targeting system, takes advantage of the
interaction between the ligand/IgG (targeting agent) immobilized on the surface of
nanoparticles and the specific receptor, which is being targeted, overexpressed on the
surface of tumor cells. It was observed that due to the enhanced permeability and
retention effect, the nanocages had an increased circulation time, which meant that they
could accumulate in the tumor site (Chen, McLellan et al. 2006).
1.2.4

Nanospheres
Chemotherapy, for different types of cancer treatment, can produce harmful side

effects since it involves saturating the body with toxic drugs (Shah and Schwartz 2001).
Using a unique drug delivery system offers advantages such as improved efficacy and
reduced toxicity. Improvement in chemotherapy can be achieved through passive or
active targeting

using gold nanospheres (Kim, Ghosh et al. 2009). There are two

different types of gold nanospheres (colloidal gold) separated by the fabrication methods,
sodium citrate reduction and sulfur reduction. Both methods produce nanoparticles of
different resonant properties (Brown, Nativo et al. 2010; Day, Bickford et al. 2010;
Gobin, Watkins et al. 2010).
Kim et al had described using gold nanoparticles as multimodal drug delivery
systems. Using the fabrication process to control the size of gold nanoparticles, which
ultimately gives its high surface area to volume ratio, the gold nanoparticles can be
loaded with multifunctional monolayers, which allows multiple functional moieties such
as drugs and targeting agents to be functionalized on the surface (Kim, Ghosh et al.
2009).
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Day and Gobin et al developed a near-infrared resonant gold-gold sulfide
nanoparticle system, not only as contrast agent, but therapeutic agents for breast cancer
treatment using photoablation (Day, Bickford et al. 2010; Gobin, Watkins et al. 2010).
The gold nanoparticles were functionalized with a conjugated anti-HER2 antibodies, this
will allow the nanoparticles to specifically bind breast carcinoma cells which overexpress
the HER2 receptor. Both reported that gold / gold-sulfide nanoparticles are a suitable
material for multifunctional agent for cancer treatment.
1.3

Synthesis & Theory
GGS nanoparticles are synthesized by reacting sodium sulfide (Na2S) or sodium

thiosulfate (Na2S2O3) with chloroauric acid (HAuCl4), using the traditional single step
method or a two-step method; although, according to published papers, this synthesis is
surrounded by the issues over structure formation of the resulting product and other
byproducts formed during the self-assembly process (Schwartzberg, Grant et al. 2007).
The traditional one-step GGS reaction is carried out by mixing 2 mM solution of HAuCl4
with 1 mM Na2S solution (after it has been aged), with a volumetric ratio of 1:2, while
stirring at room temperature (RT) (Diao and Chen 2006). However, the two-step
synthesis, discovered by Zhou et al (Figure 1), requires the HAuCl4 and Na2S solutions to
react for few minutes (first reduction) and then a second reduction, Na2S solution, is
added to formulate the metal-coatings on the nanoparticles (Zhou, Honma et al. 1994).
Both self-assembly processes will result in formation of variety of particles: colloidal
gold, GGS (circular/spherical), triangular plates, and rods (Diao and Chen 2006;
Schwartzberg, Grant et al. 2007; Gobin, Watkins et al. 2010).
HAuCl4*4H2O + Na2S*9H2O = Au2S + Au + Au2S/Au (nanoshell) + S+

(1)
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Figure 2: Spectral profiles of gold nanoparticles during the
two-step synthesis. A, B, and C are different parameters that
were used by Zhou et al for further understand the two-step
self-assembly process (Zhou, Honma et al. 1994).
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The spectral profile of the synthesized particles contains a plasmon resonance band at
wavelengths of 520–540 nm (colloidal gold) and a near infrared peak (nIR) peak between
650–1000 nm (GGS, triangular plates, and rods) (Zhou, Honma et al. 1994; Averitt,
Sarkar et al. 1997; Schwartzberg, Grant et al. 2007); however, positioning of the nIR
peak can be changed by varying the synthesis conditions (Zhou, Honma et al. 1994; Diao
and Chen 2006; Likhatskii and Mikhlin 2007; Schwartzberg, Grant et al. 2007; Gobin,
Watkins et al. 2010). For the two-step method (Figure 1), the absorbance properties are
strictly depended on the size of the initial particle growth before the second reduction
step is continued (Zhou, Honma et al. 1994); also this would require more time and be
difficult (Oldenburg, Averitt et al. 1998; Prodan, Nordlander et al. 2003), specifically
during the timing for the second reduction step to make the gold nanoparticles for optimal
tuning , compared to the one-step method. Two theories have been formulated to
determine the nIR peak, surface plasmon resonance of Au2S/Au nanoshells and GGS
aggregates (Zhou, Honma et al. 1994; Averitt, Sarkar et al. 1997; Diao and Chen 2001;
Diao and Chen 2006). Although it is hard to determine the full mechanism of the
nanoparticle growth, researchers have developed theories, equation (1) - unbalanced, on
the synthesis (Raschke, Brogl et al. 2004; Diao and Chen 2006; Schwartzberg, Grant et
al. 2007; Majimel, Bacinello et al. 2008). Schwartzberg et al. has reported formation
dithionate, S2O62-, due to oxidation of Na2S, and SO42- or SO32- species as well.
The current synthesis requires Na2S to be aged for 2-3 days, and depending on
how much of Na2S has been added, concentration or further aging of sample, it could
potentially change the nIR peak. Upon further understanding the reaction of Na2S aging,
Schwartzberg et al determined two things: (1) due to a chemical change during aging
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process of Na2S solution there was an increase in nIR absorption, and (2) that Na2S2O3 is
the likely product from Na2S aging because of oxygen exposure to form sulfur oxide
species. It was also reported that Na2S2O3 solution is more stable than Na2S solution, and
aging had no effect on the synthesis of the particles compared to Na2S aging. Although,
with the usage of Na2S2O3, it still produces same results (colloidal gold, GGS, triangular
plates, and rods), it is not known whether the same “species” are being formed or not
(Schwartzberg, Grant et al. 2007).
1.3.1

Models of Growth and Resonant Properties
Over the last few decades, the development of optically controllable

nanostructures came from Zhou et al. and later by Averitt et al., which reported
nanostructure of an Au2S/Au core/shell using HAuCl4 and Na2S (Zhou, Honma et al.
1994; Averitt, Sarkar et al. 1997). This reaction produced products with the optical
signatures of two bands: (1) 520 nm and (2) near-IR band, which is similar to gold
nanorods (Schwartzberg, Grant et al. 2007).
GGS nanoparticle synthesis has been considered due to their novel properties and
device applications, though initially the focus of the formation of the nanoparticles,
growth, is more important. Averitt et al. describes the properties of these particles as an
Au-coated dielectric nanoparticles, or gold nanoshells; the theory relates to describing
these particles as a dielectric core coated with a metal nanoshell, which occurs naturally,
in the self-assembly process, during the growth of Au/Au2S nanoparticles (Averitt,
Sarkar et al. 1997). During the development of nanoparticle growth, while using HAuCl4
and Na2S, which takes place via reduction in solution, the plasmon absorption peak in the
nIR region will shifts between 650 to 900 nm or beyond in extreme cases.
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This unique “red-shift” of the nanoparticle plasmon resonance to have a peak
wavelength in the nIR regions of the spectrum has high importance for biomedical
applications, as mentioned in the Application Section (1.2). Averitt et al. published
results show that the plasmon shift is depended by the size and the dielectric properties of
the Au2S core with Au shell. Zhou et al. stated that during the later times in the synthesis,
S2- diffuses through the thin/thick gold shell and reduces the Au2S core, further
describing that this will result in an increase in the gold shell thickness while the core
decreasing in size. Averitt et al. later described this kinetic scenario as highly unlikely
due to S2- bring not existence in aqueous solution at any pH. Furthermore, this allowed
improved understanding of some of the optical properties of Au nanoshells and helped
model the growth kinetics of these nanoparticles. The results published by Averitt et al.
indicate that the plasmon peak shift is in two-stage model of nanoparticle growth; first the
Au2S core, and second then the Au shell formation on top growing linearly over time
(Averitt, Sarkar et al. 1997).
Further studies, by Averitt et al., have demonstrated that S2- is not a dominant
aqueous species and when Na2S is mixed, the S2- reacts with the water to give HS- and
OH-. From this, the growth of Au coated Au2S nanoparticles were modeled as:
2AuCl4- + 3HS-  2Au + 3S + 3H+ + 8 Cl-

(2)(Averitt, Sarkar et al. 1997)

Both Au and Au-coated Au2S nanoparticles are grown, due to the Au and S being
available for subsequent nucleation and growth.
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CHAPTER 2: DIASYNTH
2.1

Introduction
Chemistry can essentially be divided into three categories: the study of
structures, equilibrium, and reaction rates (Conners 1990). According to Conners
et al., chemical structures are described using quantum mechanics, equilibrium is
studied by statistical mechanics and thermodynamics, and the study of rates
relates with kinetics. Kinetics can be split into physical kinetics, which deals with
physical phenomena, such as diffusion and viscosity; while the chemical kinetics
deals with the rates of chemical reactions, including both covalent and covalent
bond changes.
The rate of the reaction (Equation 2) is defined as how fast or slow a
reaction proceeds to complete the reaction.
aA + bB  cC + dD

(3)

There are several factors that can play an important role in affecting the rate of a
reaction: concentration of reactants, physical state of the reactants, temperature at
which the reaction takes occurs, and the use of a catalyst (Conners 1990;
Silberberg 2006).
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•

Concentration of reactants – The more molecules present in the
system, the more frequently the molecules will collide; therefore, the
reaction occurs at an accelerated speed (Silberberg 2006).

•

Physical state – depending on the state of the sample, it can mix
quickly, or require an outside source to aid in mixing (Silberberg
2006).

•

Temperature – at higher temperatures samples are more likely to
collide to each other by affecting the kinetic energy of the molecules
(therefore the energy of collision) (Silberberg 2006).

•

Catalyst – increases a reaction without being consumed by the reaction
itself; the catalyst effects a lower activation energy and therefore
increasing the reaction rate (Silberberg 2006).

2.2

Current methods & DiaSynth
With the use of Na2S2O3, GGS nanoparticles are more stable and can be
used for different applications as mentioned above. However, in therapeutic
applications such as nIR photothermal therapy (Gobin, Watkins et al. 2010) or
drug delivery via nIR irradiation (Ren and Chow 2003), Gobin et al. reported that
colloidal gold formation during the self-assembly process are considered a
contaminant and must be removed. Not only does this reduce the total amount of
beneficial particles available, but increase endothelial uptake of non-therapeutic
particles, and can increase immune response (Raschke, Brogl et al. 2004; Gobin,
Watkins et al. 2010). Traditionally, colloidal gold particles are removed via multistep centrifugation (Gobin, Watkins et al. 2010), which is not only time
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consuming but inefficient as well. This thesis is focused on a novel synthesis to
produce high yield and manufacturing large quantities of nIR GGS nanoparticles
with desired near infrared peak (nIR) that can be used for therapeutic applications.
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The importance of the nIR region in medicine, by using nanoparticle
technology, is due to the high transmission and low absorption of light, between
650 and 900 nm, by native tissue components such as water and hemoglobin
(Gobin, Lee et al. 2007; Day, Bickford et al. 2010). The nIR light has minimal
interference with tissue and only affects samples which absorb nIR light, which
enables minimally invasive imaging and treatment (Lowery, Gobin et al. 2006;
Huang, Jain et al. 2007; Gobin, Watkins et al. 2010; Sun, Zhang et al. 2012).
AuNPs can be used to diagnose, specifically target, and photo-thermally treat
tumors by localized hyperthermia using specific nIR lasers matching the peak
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resonance of the nanoparticles (Lowery, Gobin et al. 2006; Huang, Jain et al.
2007; Gobin, Watkins et al. 2010; Sun, Zhang et al. 2012).

The current method for producing nIR GGS nanoparticles using Na2S2O3, which
is based on a single step procedure, results in a low yield of nIR particles compared to
colloidal gold. We define this as a ratio of the absorbance of peaks, RnIR/Au , of the nIR
region (700 – 900 nm) relative to the colloidal gold peak (~530 nm) as a relative measure
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Figure 3: Spectral profile of the GGS nanoparticles with traditional single step
self-assembly process, black line represents particles as made with RnIR/Au = 0.83,
while the red line is the particles after multi-step centrifugation with RnIR/Au = 1.95.
of the yield of nIR particles. Once the GGS particles have been synthesized, colloidal
gold is then removed via a multi-step centrifugation process (Figure 3), although this
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reduces the non-nIR fractions, the overall yield is reduced at each centrifugation step, in
end dramatically reducing the yield. The multi-step centrifugation process starts with
using 25 mL of GGS nanoparticles that are synthesized, and using in a 50 mL
centrifugation tube, they are centrifuged at 1100 g for 20 min. Next, the pellet was saved
and the supernatant was re-spun at the same condition for two more times. The pellet
from the second and third spin was combined with the first; this is to maximize the pellet
collection and overall yield as depicted in Figure 3. Overall, three centrifugation steps
(3X centrifugation) was necessary to reduce the colloid peak to a minimum. Also, it is
important to note that using higher forces during centrifugation of the GGS nanoparticles
can result in a solid pellet of the nanoparticles, this would reduce the overall yield.

2.3

DiaSynth – optimized synthesis of gold / gold-sulfide nanoparticles
By slight modification in synthesis of GGS nanoparticles, using Na2S2O3 instead

of Na2S, and including results published by Averitt, Sarkar, and Schwartzberg et al. with
equations (1 & 3), we have formulated equation (4) – unbalanced.
HAuCl4*3H2O + Na2S2O3*5H2O =
Au2S + Au + Au2S/Au (nanoshell) + S+ + SO42- + NaCl + SO32- + H+ + S2O62- + Cl- +
Na+

(4)

However, in order to shift the equilibrium or kinetics to this system, there are several
available options. For example, the use of heat can increase the rate of reaction or the
kinetics (as mentioned in Section 2.1), and by factoring heat into the reaction there is a
possibility that the reaction would favor the formation of nIR absorbing particles and
increasing the quality ratio. For this thesis, by combining published methods for single-
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step self-assembly of GGS nanoparticles, and dialysis simultaneously (DiaSynth), forcing
ion-exchange (by removing reactants or products), the equilibrium of the reaction can be
shifted to favor the formation of nIR absorbing particles. The DiaSynth technique will
minimize production of AuNPs with 530 nm resonance (colloidal gold), resulting in an
increase of yield of nIR particles and a population of nanoparticles that require minimum
further processing for usage as a therapeutic agent. In addition, peak optical property
shifts due to removal of some of the non-nIR resonant population. The DiaSynth method
can increase the yield of the synthesis to have a ratio of 1.7 – 2.36; thus, centrifugation
process is not required or at minimal.
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2.4

Methods

2.4.1

Traditional One-Step Method

The purpose of this experiment is synthesis a batch of AuNPs using onestep self-assembly process with HAuCl4 and Na2S2O3; followed by a 3x
centrifugation to purify the sample.
2.4.1.1 Protocol
Hydrogen

tetrachloroaurate

(III)

trihydrate

(chloroauric

acid,

HAuCl4*3H2O) was purchased from Alfa Aesar and diluted to a concentration of
2 mM (HAuCl4, gold solution). Sodium Thiosulfate (Na2S2O3) was prepared at a
concentration

of

3

mM.

Next,

at

a

volumetric

ratio

of

2.58

(HAuCl4*3H2O:Na2S2O3), HAuCl4*3H2O and Na2S2O3 are mixed and reacted at
room temperature to allow for self-assembly of AuNPs. Next, spectral scans were
obtained after an hour of the self-assembly synthesis at room temperature (RT),
using a UV/Vis spectrophotometer (Carey 50 Varian). A Malvern Zetasizer
(ZS90) was used to characterize the GGS nanoparticles surface charge and size.
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2.4.1.2 Data/Analysis
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Figure 4: Normalized absorbance of GGS nanoparticles with traditional single step
self-assembly process, the black line represents nanoparticles as made with RnIR/Au
= 0.83 (As made), while the red line is the nanoparticles after multi-step
centrifugation with RnIR/Au = 1.95 (After 3X centrifugation).

As made

After 3X
Centrifugation

Size (nm)

34.41

34.87

Zeta
Potential
(mV)

-34.6

-36.9

Table 1: Size and zeta (charge) measurement of the particles that were
synthesized.
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2.4.1.3 Conclusion
From the given data (Section 2.1.2) using the parameters described in
Section 2.1.1, we can see that quality ratio, described in Chapter 1, of the as made
sample (one-step self-assembly process) has a poor RnIR/Au = .83. Next, after the
3X centrifugation to purify the sample the RnIR/Au increased to 1.95, indicating
that there was removal of colloidal particles.
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2.4.2

GGS “Sweep”
The purpose of this experiment is to run a “sweep” on GGS nanoparticle
synthesis on small scale using one-step self-assembly process with HAuCl4 and
Na2S2O3 to see the difference the optimal peak of GGS nanoparticles for
DiaSynth. A “sweep” is defined has a standard one-step self-assembly process,
while changing the amount of HAuCl4 or Na2S2O3 being added in an X increment.

2.4.2.1 Protocol
In 6 separate 50 mL centrifugation tubes, add 11 mL of 2 mM HAuCl4 and
3 mM Na2S2O3 ranging from 1 mL to 7 mL in 1 mL increments in each tube
separately. Next, spectral scans were obtained after an hour of the self-assembly
synthesis at room temperature (RT), using a UV/Vis spectrophotometer (Carey 50
Varian).

Sample Samples (Au + Na2S2O3) Int Ratios (Au/Na2S2O3)
11+2.5
4.40
11+3
3.67
11+3.5
3.14
RT
11+4
2.75
11+4.5
2.44
11+5
2.20
Table 2: Represents the controls that will be used in the following experiment.
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2.4.2.2 Data/Analysis
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Figure 5: GGS nanoparticle synthesis sweep using 11 mL of 2 mM HAuCl4 + X
mL of 3 mM Na2S2O3 in 1 mL increments (from 1-7).
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Figure 6: GGS nanoparticle synthesis sweep using 11 mL of 2 mM HAuCl4 + X
mL of 3 mM Na2S2O3 in 0.5 mL increments (from 2.5-5).
2.4.2.3 Conclusion
Once the sweep was complete, the spectral profile was taken for each of
the samples. Figures 5 & 6 show the spectral profile on each sample; from that it
was determined that it would be optimal to work in the range of 2 mL – 4 mL of 3
mM Na2S2O3 to be mixed with 2 mM HAuCl4.
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2.4.3

GGS Sweep on Oven Based Temperature Synthesis
The purpose of this experiment is to run a sweep on GGS nanoparticle
synthesis on small scale using one-step self-assembly process with HAuCl4 and
Na2S2O3; however, the samples were synthesized inside a temperature controlled
oven. Increasing the temperature should drive the reaction faster, which ultimately
would favor the formation of the nIR particles.

2.4.3.1 Protocol
In six separate 50 mL centrifugation tubes, add 11 mL of 2 mM HAuCl4
and 3 mM Na2S2O3 ranging from 2.5 mL to 5 mL in 0.5 mL increments in each
tube separately. Once the samples were mixed, they were added to an oven at
37°C and reacted for 1 hr. The sweep was repeated again, except using an over at
65°C. All the samples were compared to the sweep done in Section 2.4.2. Next,
spectral scans were obtained after an hour after the self-assembly process using a
UV/Vis spectrophotometer (Carey 50 Varian).
Sample Samples (Au + Na2S2O3) Int Ratios (Au/Na2S2O3)
11+2.5
4.40
11+3
3.67
37°C
11+3.5
3.14
&
11+4
2.75
65°C
11+4.5
2.44
11+5
2.20
Table 3: Represents the controls that will be used in the following experiment.
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2.4.3.2 Data/Analysis
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Figure 7: GGS nanoparticle synthesis sweep using 11 mL of 2 mM HAuCl4 + X
mL of 3 mM Na2S2O3 in 0.5 mL increments (from 2.5-5) at 37°C in an oven.
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11+2.5 65CO
11+3 65CO
11+3.5 65CO
11+4 65CO
11+4.5 65CO
11+5 65CO
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Figure 8: GGS nanoparticle synthesis sweep using 11 mL of 2 mM HAuCl4 +
X mL of 3 mM Na2S2O3 in 0.5 mL increments (from 2.5-5) at 65°C in an oven.
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Int Ratios
nIR Wavelength
Quality Ratio
(HAuCl4/Na2S2O3)
Peak (nm)

RT

37 CO

4.40

N/A

N/A

3.67
3.14
2.75
2.44
2.20
4.40

995
901
852
807
779
1025

1.675
1.398
1.126
0.895
0.730
0.773

3.67
3.14
2.75
2.44
2.20
4.40

987
901
859
801
785
N/A

1.665
1.370
1.135
0.885
0.713
N/A

3.67
897
1.432
3.14
822
1.203
2.75
813
0.990
2.44
807
0.929
2.20
787
0.770
Table 9: nIR peak and the quality ratios of each sample from Figure 6, 7, and 8.
65 CO
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Figure 9: Scatter plot (data from Table 4) of the initial ratio (HAuCl4 : Na2S2O3) used vs the nIR peak at the end of the reaction
is the given three controls.
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Figure 10: Scatter plot (data from Table 4) of the initial ratio (HAuCl4 : Na2S2O3) used vs the RnIR/Au at the end of the reaction
is the given three controls.
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2.4.3.3 Conclusion
Once the sweep was complete, the spectral profile was taken for each of
the samples. Figures 7 & 8 show the spectral profile on each sample; from that it
was determined that it would be optimal to work in the range of 2 mL – 4 mL of 3
mM Na2S2O3 to be mixed with 2 mM HAuCl4, same as the data reported in
Section 2.4.2. The sample will be tested in a water bath to see if it will aid in the
reaction rate.
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2.4.4

GGS Synthesis in Water Bath & Oven - Temperature Controlled
Environment
The purpose of this experiment is to synthesize GGS nanoparticle on small
scale using one-step self-assembly process with HAuCl4 and Na2S2O3; however,
the samples were synthesized inside a temperature controlled oven and water bath
(repeat of experiment in Section 2.4.3).

2.4.4.1 Protocol
Fill a 1 L beaker with 800 mL of DI water and heat the water to 37°C or
65°C. Next, using a 50 mL centrifugation tubes, add a mixture of 11 mL of 2 mM
HAuCl4 and 2 or 3 mL of 3 mM Na2S2O3, and let the sample react for 1 hour at
RT, 37°C, and 65°C. Next, spectral scans were obtained after an hour of the selfassembly synthesis at room temperature (RT), 37°C, and 65°C. Next, spectral
scans were obtained after an hour after the self-assembly process using a UV/Vis
spectrophotometer (Carey 50 Varian).
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2.4.4.2 Data/Analysis

RT 11+2
37 Oven 11+2
65 Oven 11+2
37 WB 11+2
65 WB 11+2

1.0

Absorbance

0.8

0.6

0.4

0.2

0.0
400

500

600

700

800

900

1000

1100

Wavelength (nm)
Figure 11: GGS nanoparticle synthesis using 11 mL of 2 mM HAuCl4 + 2 mL of 3
mM Na2S2O3 in a water bath and an oven at 35°C or 65°C.
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Figure 12: GGS nanoparticle synthesis using 11 mL of 2 mM HAuCl4 + 3 mL of 3
mM Na2S2O3 in a water bath and an oven at 35°C or 65°C.
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Samples

Int Ratio

nIR Wavelength
Peak (nm)

Quality Ratio

5.5

N/A

N/A

3.67

990

1.663

5.5

N/A

N/A

3.67

919

1.164

5.5

N/A

N/A

3.67

902

1.271

5.5

N/A

N/A

3.67

930

1.496

5.5

N/A

N/A

3.67

826

1.270

RT

37C Oven

65C Oven

37C WB

65C WB

Table 4: nIR peak and the quality ratios of each sample from Figure 11 and 12.
2.4.4.3 Conclusion
Once the self-assembly process was complete, the spectral profile was
taken for each of the samples. Figures 11 & 12 show the spectral profile on each
sample; from that it was determined that it using the water bath shows better
results for 11+3, and had better quality ratio.
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2.4.5

GGS Synthesis in Water Bath - Temperature Controlled Environment
The purpose of this experiment is to synthesize GGS nanoparticle on small
scale using one-step self-assembly process with HAuCl4 and Na2S2O3; however,
the samples were synthesized inside a temperature controlled water bath (repeat
of experiment in Section 2.4.3 and 2.4.4). However in those experiments the
volume of Na2S2O3 is changed, but instead for this experiment the HAuCl4 will be
changed.

2.4.5.1 Protocol
Fill a 1 L beaker with 800 mL of DI water and heat the water to 37°C
(WB) or 100°C (HB). Next, using a 50 mL centrifugation tubes, add a mixture of
8 mL, 9 mL, 10 mL, or 11 mL of 2 mM HAuCl4 and 3 mL of 3 mM Na2S2O3, and
let the sample react for 1 hour at RT, 37°C, and 100°C. Next, spectral scans were
obtained after an hour of the self-assembly synthesis at room temperature (RT),
37°C, and 100°C.
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2.4.5.2 Data/Synthesis
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Figure 13: Spectral profile of the RT synthesis, using a mixture of 8 mL, 9 mL, 10
mL, or 11 mL of 2 mM HAuCl4 and 3 mL of 3 mM Na2S2O3.
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Figure 14: Spectral profile of the 37°C water bath synthesis, using a mixture of 8 mL, 9
mL, 10 mL, or 11 mL of 2 mM HAuCl4 and 3 mL of 3 mM Na2S2O3.

53

HB 8ml
HB 9ml
HB 10ml
HB 11ml

1.0

Absorbance

0.8

0.6

0.4

0.2

0.0
400

500

600

700

800

900

1000

1100

Wavelength (nm)
Figure 15: Spectral profile of the 100°C water bath synthesis, using a mixture of 8
mL, 9 mL, 10 mL, or 11 mL of 2 mM HAuCl4 and 3 mL of 3 mM Na2S2O3.
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Int Ratios
(Au/Na2S2O3)

nIR Wavelength
Peak (nm)

Quality Ratio

2.67

912

1.103

3.00

955

1.458

3.33

953

1.591

3.67

964

1.700

2.67

863

1.064

3.00

908

1.265

3.33

851

1.380

3.67

908

1.858

2.67

716

0.789

3.00

736

0.817

3.33

749

0.908

3.67

720

1.193

RT

37 C

100 C

Table 5: nIR peak and the quality ratios of each sample from Figure 13, 14 and 15.
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Figure 16: Scatter plot (data from Table 6) of the initial ratio (HAuCl4 : Na2S2O3) used vs the RnIR/Au at the end of the reaction
is the given three controls..
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Figure 17: Scatter plot (data from Table 6) of the initial ratio (HAuCl4 : Na2S2O3) used vs the nIR peak at the end of the
reaction is the given three controls.
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2.4.5.3 Conclusion
Once the self-assembly process was complete, the spectral profile was taken for
each of the samples. Figures 13, 14, & 15, show the spectral profile on each sample. At
higher temperatures samples are colliding faster to each other, which ultimately affecting
the kinetic energy of the molecules, and driving the reaction. For the series of
temperature studies, the kinetics was changed and shown to have an RnIR/Au > 1.2. Most
of the reaction show that using the 11+3 samples has a better ratio, using the initial for
the DiaSynth studies could be beneficial.
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2.4.6

DiaSynth
The purpose of this experiment is to synthesize a batch of AuNPs with
HAuCl4 and Na2S2O3 using the DiaSynth method, dialyzed against DI water at
room temperature. Also, HAuCl4 dialyzed against Na2S2O3 to see the kinetics and
equilibrium shift of two different reactions.

2.4.6.1 Protocol
Fill a 1 L beaker with 800 mL of DI water and place stir bar inside. Next,
using a 3500 Da MWCO Dialysis membrane, add a mixture of 11 mL of 2 mM
HAuCl4 (first in the bag) and 3 mL of 3 mM Na2S2O3 (second after the gold
solution had been added), and let the sample dialyze for 1 hour (Sample 1).
Separately, fill a 1L beaker with 3 mM Na2S2O3. Next to that, add 25 mL of 2
mM HAuCl4 in a 3500 Da MWCO Dialysis membrane and let it react for 2.5
hours (Sample 2). For a non-dialysis sample, 11 mL of 2 mM HAuCl4 and 3 mL
of 3 mM Na2S2O3 are mixed in a 50 mL tube and reacted for 1 hr as well (Sample
3). Next, spectral scans were obtained after an hour of the self-assembly synthesis
at room temperature (RT), using a UV/Vis spectrophotometer (Carey 50 Varian).
A Malvern Zetasizer (ZS90) was used to characterize the GGS nanoparticles
surface charge and size.
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2.4.6.2 Data/Analysis
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Figure 18: Normalized absorbance and spectral profile of GGS nanoparticles
synthesized using various parameters. (Sample 1, black-square line) 11 mL of 2
mM HAuCl4 mixed with 3 mL of 3 mM Na2S2O3 dialyzed against DI water with
RnIR/Au = 1.4. (Sample 2) 25 mL of 2 mM HAuCl4 dialyzed against 1 L of Na2S2O3
for 2.5 hrs (blue-triangle line). (Sample 3, red-circle line) Non-dialyzed sample
using 11 mL of 2 mM HAuCl4 mixed with 3 mL of 3 mM Na2S2O3 with RnIR/Au =
1.53.
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(A)

(B)

(C)

(D)

(E)

(F)

(G)

(H)

Figure 19: Image of Non-Dialysis synthesis and dialyzed synthesis over 1 hr time period. (A - D) Image of non-dialyzed
sample at 30 secs, 5 mins, 30 mins, and 1 hr, respectfully. (E - F) Image of Dialyzed sample at 30 secs, 5 mins, 30 mins, and
1 hr, respectfully.
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2.4.6.3 Conclusion
From the given data, we can see that 11 mL of 2 mM HAuCl4 mixed with
3 mL of 3 mM Na2S2O3 in a 3500 Da MWCO Dialysis membrane, dialyzed
against DI water has the best nIR RnIR/Au = 1.4; while the non-dialyzed sample had
RnIR/Au = 1.53. Sample dialyzed against Na2S2O3 had pure colloid formation, and
had RnIR/Au < 1.
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2.4.7

DiaSynth (repeat of 2.4.6 with extended time)
The purpose of this experiment is to synthesize a batch of AuNPs with
HAuCl4 and Na2S2O3 using the DiaSynth method, dialyzed against DI water at
room temperature. Also, HAuCl4 dialyzed against Na2S2O3 for an extended period
of time to see the kinetics and equilibrium shift of two different reactions.

2.4.7.1 Protocol
Fill a 1 L beaker with 800 mL of DI water and place stir bar inside. Next,
using a 3500 Da MWCO Dialysis membrane, add a mixture of 11 mL of 2 mM
HAuCl4 (first in the bag) and 3 mL of 3 mM Na2S2O3 (second after the gold
solution had been added), and let the sample dialyze for 1 hour (Sample 1).
Separately, fill a 1L beaker with 3 mM Na2S2O3. Next to that, add 25 mL of 2
mM HAuCl4 in a 3500 Da MWCO Dialysis membrane and let it react for 5 hours
(Sample 2 & 3). For a non-dialysis sample, 11 mL of 2 mM HAuCl4 and 3 mL of
3 mM Na2S2O3 are mixed in a 50 mL tube and reacted for 1 hr as well (Sample 4).
Next, spectral scans were obtained after an hour of the self-assembly synthesis at
room temperature (RT), using a UV/Vis spectrophotometer (Carey 50 Varian). A
Malvern Zetasizer (ZS90) was used to characterize the GGS nanoparticles surface
charge and size.
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2.4.7.2 Data/Analysis
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Figure 20: Non-normalized absorbance and spectral profile of GGS
nanoparticles synthesized using various parameters. (Sample 1, black-square
line) 11 mL of 2 mM HAuCl4 mixed with 3 mL of 3 mM Na2S2O3 dialyzed against
DI water with RnIR/Au = 1.4. (Sample 2 & 3, respectively) 25 mL of 2 mM HAuCl4
dialyzed against 1 L of Na2S2O3 for 2.5 hrs (blue-triangle line) and 5 hrs (pink
line-triangle-down line), both with RnIR/Au < 1. (Sample 4, red-circle line) Nondialyzed sample using 11 mL of 2 mM HAuCl4 mixed with 3 mL of 3 mM
Na2S2O3 with RnIR/Au = 1.59.
2.4.7.3 Conclusion
From the given data, we can see that 11 mL of 2 mM HAuCl4 mixed with
3 mL of 3 mM Na2S2O3 in a 3500 Da MWCO Dialysis membrane, dialyzed
against DI water, has the best nIR RnIR/Au = 1.4; while the non-dialyzed sample
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had RnIR/Au = 1.59. The extended dialysis sample dialyzed against Na2S2O3 had
pure colloid formation, and had RnIR/Au < 1.
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2.4.8

DiaSynth - with time and int. ratio variation
The purpose of this experiment is to synthesize a batch of AuNPs with
HAuCl4 and Na2S2O3 using the DiaSynth method, dialyzed against DI water at
room temperature. However, from the previous studies, Section 2.4.6 & 2.4.7,
samples with 11 mL of 2 mM HAuCl4 mixed with 3 mL of 3 mM Na2S2O3 in a
3500 Da MWCO Dialysis membrane showed the best result. The experiment will
use the sample initial ratio (11+3, 11 mL of 2 mM HAuCl4 mixed with 3 mL of 3
mM Na2S2O3 or HAuCl4:Na2S2O3, used for dialysis) as well as 11+2, while
extending the dialysis time to 2 hrs and including non-dialysis controls.

2.4.8.1 Protocol
Fill 4 - 1 L beaker with 800 mL of DI water and place stir bar inside. Next,
using a 3500 Da MWCO Dialysis membrane, add a mixture of 11 mL of 2 mM
HAuCl4 (first in the bag) and 2 (Sample 1) or 3 (Sample 2) mL of 3 mM Na2S2O3
(second after the gold solution had been added), and let the sample dialyze for 1
(Sample 1 & 2) hr & 2 hrs (Sample 3 & 4). For a non-dialysis sample, 11 mL of 2
mM HAuCl4 and 2 (Sample 5) or 3 (Sample 6) mL of 3 mM Na2S2O3 are mixed
in a 50 mL tubes and reacted for 1 hr. Next, spectral scans were obtained after an
hour of the self-assembly synthesis at room temperature (RT), using a UV/Vis
spectrophotometer (Carey 50 Varian). A Malvern Zetasizer (ZS90) was used to
characterize the GGS nanoparticles surface charge and size.
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2.4.8.2 Data/Analysis
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Figure 21: Normalized absorbance and spectral profile of GGS nanoparticles
synthesized using various parameters. (Sample 1 & 3, red-circle & blue-triangle
line respectively) 11 mL of 2 mM HAuCl4 mixed with 2 mL of 3 mM Na2S2O3
dialyzed against DI water for 1 & 2 hrs, respectively, with RnIR/Au = 2.01 & 1.65,
respectively. (Sample 5, black-square line) Non-dialyzed sample using 11 mL of 2
mM HAuCl4 mixed with 2 mL of 3 mM Na2S2O3 with RnIR/Au = N/A, due to the
unknown nIR peak (out of range).

67

1.0

Absorbance

0.8

0.6

0.4

0.2

0.0
400

500

600

700

800

900

1000

1100

Wavelength (nm)
Figure 22: Normalized absorbance and spectral profile of GGS nanoparticles
synthesized using various parameters. (Sample 2 & 4, red-circle & blue-triangle
line respectively) 11 mL of 2 mM HAuCl4 mixed with 3 mL of 3 mM Na2S2O3
dialyzed against DI water for 1 & 2 hrs, respectively, with RnIR/Au = 1.58 & 1.49,
respectively. (Sample 6, black-square line) Non-dialyzed sample using 11 mL of 2
mM HAuCl4 mixed with 3 mL of 3 mM Na2S2O3 with RnIR/Au = 1.53.

2.4.8.3 Conclusion
Using the 11 mL of 2 mM HAuCl4 and 2 mL of 3 mM Na2S2O3 dialyzed
against DI Water for 2 hrs has a RnIR/Au = 1.65, not only does this show that
dialyzing for 1 hr shifts the equilibrium of the synthesis, but further (extended
time) dialysis shifts the equilibrium even more on the 2000 Da MWCO Dialysis
membrane. The initial ratios that are being using should be used
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2.4.9

DiaSynth - using high temperature
The purpose of this experiment is to synthesize a batch of AuNPs with
HAuCl4 and Na2S2O3 using the DiaSynth method, dialyzed against DI water at
various temperatures including room temperature as a control.

2.4.9.1 Protocol
Fill 4 - 1 L beaker with 800 mL of DI water, two with DI water at 100° C,
one with DI water at 65° C, and one with room temperature (RT) DI water, and
place stir bar inside. Next, using a 3500 Da MWCO Dialysis membrane, add a
mixture of 11 mL of 2 mM HAuCl4 (first in the bag) and 3 mL of 3 mM Na2S2O3
(second after the gold solution had been added), and let the sample dialyze for 1
hour.
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2.4.9.2 Data/Analysis
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Figure 23: Normalized absorbance and spectral profile of GGS nanoparticles
synthesized using DiaSynth method with various temperature of DI water.
(Black-square line) Sample with RT DI water has highest RnIR/Au = 1.48. The rest
of the controls with high DI water temperature had RnIR/Au < 1.
2.4.9.3 Conclusion
When placing the dialysis membrane in the DI water at 100° C, the sample
started to react very fast and changed colors, therefore one sample ran for 5 mins
(blue line) and the other for 15 mins (pink line). From the spectral profile,
overtime samples had just pure colloid formation. Compared to the RT sample,
this is relative close to what was previously synthesized; also the sample with DI
water at 65° C (reacted for the full 1 hr) had similar results to the 100 ° C sample.
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2.4.10 DiaSynth - 1,2 step
The purpose of this experiment is to synthesize a batch of AuNPs with
HAuCl4 and Na2S2O3 using the DiaSynth method, dialyzed against DI water with
the one-step and two-step techniques described in the introduction section, except
instead of using a 1 L beaker, the experiment will use an 8 L bucket. Also, from
the previous experiments the AuNPs are aggregating, indicating that the particles
are not stable, therefore once the experiment is finished chitosan (CS) will be
added to stabilize the AuNPs.

2.4.10.1

Protocol
Fill 2 – 8 L beaker with 7.5 – 8 L of DI water and place stir bar inside.

Next, using a 3500 Da MWCO Dialysis membrane, add a mixture of 11 mL of 2
mM HAuCl4 (first in the bag) and 3 mL of 3 mM Na2S2O3 (second after the gold
solution had been added), and let the sample dialyze for 1 hour (Sample 1). Next
for the two-step reaction, 4 mL of 2 mM HAuCl4 and 3 mL of 3 mM Na2S2O3 is
reacted for 30 secs, in a 3500 Da MWCO Dialysis membrane, and 7 mL of 2 mM
HAuCl4 is additionally added in the 3500 Da MWCO Dialysis membrane and
allow reaction for an hour (Sample 2). For the non-dialyzed samples, 11 mL of 2
mM HAuCl4 and 3 mL of 3 mM Na2S2O3 are mixed in a 50 mL tube and reacted
for 1 hr for the one-step process (Sample 3); additionally, a two-step process is
done in the similar fashion as described above (Sample 4). Next, once the reaction
is complete CS is added to stabilize the particles.
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2.4.10.2

Data/Analysis
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Figure 24: Normalized absorbance and spectral profile of GGS nanoparticles
synthesized using DiaSynth method with one-step (Sample 1, blue-triangle line),
two-step (Pink-triangle-down line), and Non-dialyzed samples, one step (Sample
3, black-square line) and two-step (red-circle line). The nIR peak and ratio are
reported in Table 2.
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Figure 25: Normalized absorbance and spectral profile of GGS nanoparticles
synthesized using DiaSynth method with one-step (Sample 1, blue-triangle line),
two-step (Pink-triangle-down line), and Non-dialyzed samples, one step (Sample
3, black-square line) and two-step (red-circle line), after adding in the CS
overnight. The nIR peak and quality ratio are reported in Table 2.
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Controls

nIR Peak

Ratio

Sample 1

805

1.66

Sample 2

842

1.85

Sample 3

856

1.40

Sample 4

1095

2.04

Sample 1

750

1.43

Sample 2

784

1.49

Sample 3

807

1.27

Sample 4

1074

2.20

Before CS

After CS

Table 6: nIR peak and the ratios of each sample before and after adding the CS.

2.4.10.3

Conclusion
Using the DiaSynth method, compared to traditional method including 2-

step method, the results show that DiaSynth method has high quality ratio. The
ratios and the nIR peak of the different parameters are provided in Table 7. Next,
in order to stabilize the AuNPs, CS was added to them over night and spectral
profile was measured the following day which show there was no significant
changes; therefore the particles are more stable.
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2.4.11 DiaSynth – repeat of Section 2.4.10

The experiment in Section 2.4.10 is being repeated after washing the
dialysis membrane very carefully. The purpose of this experiment is to synthesize
a batch of AuNPs with HAuCl4 and Na2S2O3 using the DiaSynth method,
dialyzed against DI water at room temperature. However, from the previous
studies, Section 2.3 & 2.4, samples with 11 mL of 2 mM HAuCl4 mixed with 3
mL of 3 mM Na2S2O3 in a 3500 Da MWCO Dialysis membrane showed the best
result. The experiment will use the sample initial ratio (11+3) as well as 11+2,
while extending the dialysis time to 4 hrs and using a 2000 Da MWCO Dialysis
membrane with non-dialysis controls.

2.4.11.1

Protocol
Fill 6 – 8 L bucket with 7.5 – 8 L of DI water and place stir bar inside.

Next, using 3 of the 6 - 8 L buckets, add, in three separate 3500 Da MWCO
Dialysis membrane, a mixture of 11 mL of 2 mM HAuCl4 (first in the bag) and 3
mL of 3 mM Na2S2O3 (second after the gold solution had been added), and let the
sample dialyze for 1, 2, and 4 hours in separate buckets (Sample 1, 2, and 3,
respectively). Repeat everything from using the other three 8 L bucket, except
using 2000 Da MWCO Dialysis membrane for 1, 2, and 4 hours in separate
buckets (Sample 4, 5, and 6, respectively). Then for a non-dialysis sample, 11 mL
of 2 mM HAuCl4 and 2 (Sample 7) or 3 (Sample 8) mL of 3 mM Na2S2O3 are
mixed in a 50 mL tubes and reacted for 1 hr. Next, spectral scans were obtained
after an hour of the self-assembly synthesis at room temperature (RT), using a
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UV/Vis spectrophotometer (Carey 50 Varian). A Malvern Zetasizer (ZS90) and
TEM (FEI Tecnai F20) were used to characterize the GGS nanoparticles surface
charge, size, and morphology.
2.4.11.2

Data/Analysis
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Figure 26: Normalized absorbance and spectral profile of GGS nanoparticles
synthesized using DiaSynth method with 2000 MWCO Dialysis membrane, a
mixture of 11 mL of 2 mM HAuCl4 and 3 mL of 3 mM Na2S2O3 is added. The
sample were dialyze for 1 (red-circle line), 2 (blue-triangle line), and 4 (pinktriangle-down line). Non-dialyzed sample using 11 mL of 2 mM HAuCl4 mixed
with 3 mL of 3 mM Na2S2O3 is used as a control (black-square line). nIR peak
and quality ratio are reported in Table 8.
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Figure 27: Normalized absorbance and spectral profile of GGS nanoparticles
synthesized using DiaSynth method with 3500 MWCO Dialysis membrane, a
mixture of 11 mL of 2 mM HAuCl4 and 3 mL of 3 mM Na2S2O3 is added. The
sample were dialyze for 1 (red-circle line), 2 (blue-triangle line), and 4 (pinktriangle-down line). Non-dialyzed sample using 11 mL of 2 mM HAuCl4 mixed
with 3 mL of 3 mM Na2S2O3 is used as a control (black-square line). nIR peak
and quality ratio are reported in Table 8.
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Figure 28: Normalized absorbance and spectral profile of GGS nanoparticles
synthesized using DiaSynth method with 2000 MWCO Dialysis membrane, a
mixture of 11 mL of 2 mM HAuCl4 and 2 mL of 3 mM Na2S2O3 is added. The
sample were dialyze for 1 (red-circle line), 2 (blue-triangle line), and 4 (pinktriangle-down line). Non-dialyzed sample using 11 mL of 2 mM HAuCl4 mixed
with 2 mL of 3 mM Na2S2O3 is used as a control (black-square line). nIR peak
and quality ratio are reported in Table 9.
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Figure 29: Normalized absorbance and spectral profile of GGS nanoparticles
synthesized using DiaSynth method with 3500 MWCO Dialysis membrane, a
mixture of 11 mL of 2 mM HAuCl4 and 2 mL of 3 mM Na2S2O3 is added. The
sample were dialyze for 1 (red-circle line), 2 (blue-triangle line), and 4 (pinktriangle-down line). Non-dialyzed sample using 11 mL of 2 mM HAuCl4 mixed
with 2 mL of 3 mM Na2S2O3 is used as a control (black-square line). nIR peak
and quality ratio are reported in Table 9.

79

Non-Dialysis

2000 Da
MWCO Dialysis

3500 Da
MWCO Dialysis

Samples (11+3)

nIR Wavelength Peak
(nm)

Quality Ratio

1 hr

959

1.539

1 hr

899

1.357

2 hr

926

1.416

4 hr

930

1.444

1 hr

816

1.527

2 hr

815

1.620

4 hr

819

1.573

Table 7: nIR peak and the quality ratios of each sample from Figure 26 and 27.

Non-Dialysis

2000 Da MWCO
Dialysis

3500 Da MWCO
Dialysis

Samples (11+2)

nIR Wavelength
Peak (nm)

Quality Ratio

1 hr

N/A

N/A

1 hr

N/A

N/A

2 hr

N/A

N/A

4 hr

N/A

N/A

1 hr

1027

2.005

2 hr

773

1.678

4 hr

852

1.820

Table 9: nIR peak and the quality ratios of each sample from Figure 28 and 29.
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Figure 29: Graph of the nIR peak of samples from Tables 8 & 9, X-axis is dialysis time (in hrs) for each control, Y-Axis
is the initial ratio used to synthesize the AuNPs, and Z-axis nIR peak of the AuNPs after the synthesis.
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Figure 30: Graph of the quality ratio of samples from Tables 8 & 9, X-axis is dialysis time (in hrs) for each control,
Y-Axis is the initial ratio used to synthesize the AuNPs, and Z-axis quality ratio of the AuNPs after the synthesis..
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Figure 31: TEM images of Dialyzed and non-dialyzed samples. Top row – Non-dialysis sample, Middle row –
DiaSynth using 2000 MWCO Dialysis membrane, and Bottom row DiaSynth using 3500 MWCO Dialysis membrane.
83
For column 1 & 2 samples are at 100X, while column 3 samples are at 500X.

2.4.11.3

Conclusion
After noticing that dialysis membrane are soaked a preservative called

sodium azide, which could potentially be the cause of the aggregation, the dialysis
membrane are thoroughly washed with DI water, and then placed in the DI water
with the HAuCl4 and Na2S2O3. This experiment was repeated from Section 2.5,
using DiaSynth along with the controls shown in Tables 8 & 9. The data shows
that using the 3500 Da MWCO Dialysis membrane with a mixture of 11 mL of 2
mM HAuCl4 and 3 mL of 3 mM Na2S2O3 dialyzed for 1, 2, or 4 hrs, has the best
RnIR/Au = 1.57, 1.62, and 1.57, respectfully. The TEM samples were prepared
using the 1 hr samples for each control on 11+3 (non-dialysis and 2000 & 3500
Da MWCO Dialysis membrane). From the TEM images, it should that there is
less production of the colloidal particles when using the DiaSynth method.

84

2.4.12 DiaSynth Sweep
The purpose of this experiment is to run a sweep on GGS nanoparticle
synthesis with DiaSynth method, using 11 mL of 2 mM HAuCl4 mixed with
various “X mL” of 3 mM Na2S2O3 in 2000 and 3500 Da MWCO Dialysis
membrane to show the best quality ratio.

2.4.12.1

Protocol
Fill an 8 L bucket with 7.5 – 8 L of DI water and place stir bar inside.

Next, in a 3500 Da MWCO Dialysis membrane, a mixture of 11 mL of 2 mM
HAuCl4 (first in the bag) and 2.5 mL to 5 mL in 0.5 mL increments mL of 3 mM
Na2S2O3 (second after the gold solution had been added), and let the sample
dialyze for 1 hr. Repeat the experiment, except using 2000 Da MWCO Dialysis
membrane. Then for a non-dialysis sample, 11 mL of 2 mM HAuCl4 and 2.5 mL
to 5 mL in 0.5 mL increments of 3 mM Na2S2O3 are mixed in a 50 mL tubes and
reacted for 1 hr (Table 10 shows the list of the controls used in this experiment).
In 6 separate 50 mL centrifugation tubes, add 11 mL of 2 mM HAuCl4 and 3 mM
Na2S2O3 ranging from 2.5 mL to 5 mL in 0.5 mL increments in each tube
separately. Next, spectral scans were obtained after an hour of the self-assembly
synthesis at room temperature (RT), using a UV/Vis spectrophotometer (Carey 50
Varian). A Malvern Zetasizer (ZS90) was used to characterize the GGS
nanoparticles surface charge and size.
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Samples

Samples (Au + Na2S2O3)

Int Ratios (Au/Na2S2O3)

11+2.5
4.40
11+3
3.67
11+3.5
3.14
Non-Dialysis
11+4
2.75
11+4.5
2.44
11+5
2.20
11+2.5
4.40
11+3
3.67
11+3.5
3.14
2000 Da MWCO Dialysis
11+4
2.75
11+4.5
2.44
11+5
2.20
11+2.5
4.40
11+3
3.67
11+3.5
3.14
3500 Da MWCO Dialysis
11+4
2.75
11+4.5
2.44
11+5
2.20
Table 10: Represents the controls that will be used in the following experiment.
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Data/Analysis
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Figure 32: GGS nanoparticle sweep with DiaSynth method using 11 mL of 2 mM
HAuCl4 + X mL of 3 mM Na2S2O3 in 0.5 mL increments (from 2.5-5) in a 2000
MWCO Dialysis membrane. The Black-square, Red-circle, Blue-triangle, Pinktriangle-down, Green-square, and Purple-triangle-side line represents the
spectral profile of the samples with 2.5, 3, 3.5, 4, 4.5, and 5 mL of 3 mM Na2S2O3.
The nIR peak and quality ratio is reported in Table 11.

87

1.0

Absorbance

0.8

0.6

0.4

0.2

0.0
400

500

600

700

800

900

1000

1100

Wavelength (nm)
Figure 33: GGS nanoparticle sweep with DiaSynth method using 11 mL of 2
mM HAuCl4 + X mL of 3 mM Na2S2O3 in 0.5 mL increments (from 2.5-5) in a
3500 MWCO Dialysis membrane. The Black-square, Red-circle, Blue-triangle,
Pink-triangle-down, Green-square, and Purple-triangle-side line represents the
spectral profile of the samples with 2.5, 3, 3.5, 4, 4.5, and 5 mL of 3 mM
Na2S2O3. The nIR peak and quality ratio is reported in Table 11.
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Int Ratios
nIR Wavelength
Quality Ratio
(HAuCl4/Na2S2O3)
Peak (nm)

Non-Dialysis

2000 Da MWCO
Dialysis

3500 Da MWCO
Dialysis

4.40
3.67
3.14
2.75
2.44
2.20
4.40
3.67
3.14
2.75
2.44
2.20
4.40
3.67
3.14
2.75
2.44
2.20

N/A
995
901
852
807
779
931
928
950
848
771
771
789
816
820
834
789
747

N/A
1.675
1.398
1.126
0.895
0.730
1.588
1.421
1.436
1.209
0.783
0.787
1.804
1.731
1.621
1.352
1.038
0.787

Table 11: nIR peak and the quality ratios of each sample from Figure 33 & 34.

89

1000

Non-Dialysis
2000 MWCO Dialysis
3500 MWCO Dialysis

Wavelength (nm)

950
900
850
800
750
700
2.00

2.50

3.00

3.50

4.00

4.50

Int Ratio (HAuCl4/Na2S2O3)
Figure 34: Scatter plot (data from Table 11) of the initial ratio (HAuCl4 : Na2S2O3) used vs the nIR peak at the end of the
reaction is the given three controls.
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Figure 35: Scatter plot (data from Table 11) of the initial ratio (HAuCl4 : Na2S2O3) used vs the RnIR/Au at the end of the
reaction is the given three controls.

91

2.4.12.3

Conclusion
From the given data, the sample with 11 mL of 2 mM HAuCl4 mixed with

2.5 mL of 3 mM Na2S2O3 in a 3500 Da MWCO Dialysis membrane, dialyzed
against DI water, has the best nIR RnIR/Au = 1.8; while the 2000 Da MWCO
Dialysis membrane and

non-dialyzed sample has RnIR/Au = 1.58 and N/A,

respectfully. Future studies will focus on using the 11 mL of 2 mM HAuCl4
mixed with 2.5 mL of 3 mM Na2S2O3 (11+2.5, 4.4 Initial ratio) ratio.
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2.4.13 DiaSynth - using higher MWCO bags
The purpose of this experiment is to synthesize a batch of AuNPs with
HAuCl4 and Na2S2O3 using the DiaSynth method, dialyzed against DI water at
room temperature. However, this experiment will use 4 different dialysis
membrane, 2000 Da MWCO, 3500 Da MWCO, 6000 - 8000 Da MWCO, and
12000 Da MWCO dialysis membranes.

2.4.13.1

Protocol
Fill 4 - 8 L bucket with 7.5 – 8 L of DI water and place stir bar inside.

Next, prepare 4 mixtures of 11 mL of 2 mM HAuCl4 (first in the bag) and 2.5 mL
of 3 mM Na2S2O3 (second after the gold solution had been added) is added to
2000 Da MWCO, 3500 Da MWCO, 6000 - 8000 Da MWCO, and 12000 Da
MWCO dialysis membrane separately, and let the samples dialyze for 1. Then for
a non-dialysis sample, 11 mL of 2 mM HAuCl4 and 2.5 mL of 3 mM Na2S2O3 is
mixed in a 50 mL tubes and reacted for 1 hr. Next, spectral scans were obtained
after an hour of the self-assembly synthesis at room temperature (RT), using a
UV/Vis spectrophotometer (Carey 50 Varian).
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Figure 36: Normalized spectral profile of AuNPs synthesized using the
DiaSynth method with 4 different MWCO bags.
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Samples

nIR Wavelength Peak
(nm)

Quality Ratio

Non-Dialysis

1098

2.58

2KDa MWCO Dialysis

858

1.35

3.5KDa MWCO Dialysis

748

1.54

6-8KDa MWCO Dialysis

744

1.57

12KDa MWCO Dialysis

799

1.65

Table 12: nIR peak and the quality ratios of each sample from Figure 37.

2 Kda
MWCO
Dialysis

3.5 Kda
MWCO
Dialysis

6-8 Kda
MWCO
Dialysis

12 Kda
MWCO
Dialysis

Size (nm)

43.64

38.94

41.22

42.25

Zeta Potential
(mV)

-26.4

-35.2

-29.95

-30.25

Table 13: Size and zeta measurements of the samples.
2.4.13.3

Conclusion
From the given data (Figure 37 & Table 12), the sample with 11 mL of 2

mM HAuCl4 mixed with 2.5 mL of 3 mM Na2S2O3 in a 12000 Da MWCO
Dialysis membrane, dialyzed against DI water, has the best nIR RnIR/Au = 1.7;
while the other MWCO Dialysis membrane has a lower RnIR/Au. Future studies
will focus on using the 11 mL of 2 mM HAuCl4 mixed with 2.5 mL of 3 mM
Na2S2O3 (11+2.5, 4.4 Initial ratio) ratio with 12000 Da MWCO Dialysis
membrane.
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2.4.14 DiaSynth – 12 KDa MWCO Sweep
The purpose of this experiment is to run a sweep on GGS nanoparticle
synthesis with DiaSynth method, using 11 mL of 2 mM HAuCl4 mixed with
various “X mL” of 3 mM Na2S2O3 in 12000 Da MWCO Dialysis membrane to
show the best quality ratio.

2.4.14.1

Protocol
Fill an 8 L bucket with 7.5 – 8 L of DI water and place stir bar inside.

Next, in a 12000 Da MWCO Dialysis membrane, a mixture of 11 mL of 2 mM
HAuCl4 (first in the bag) and 2.5 mL to 3.5 mL in 0.5 mL increments mL of 3
mM Na2S2O3 (second after the gold solution had been added), and let the sample
dialyze for 1. Next, spectral scans were obtained after an hour of the selfassembly synthesis at room temperature (RT), using a UV/Vis spectrophotometer
(Carey 50 Varian). A Malvern Zetasizer (ZS90) was used to characterize the GGS
nanoparticles surface charge and size.
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Data/Analysis

2.5 mL
3 mL
3.5 mL

1.0

Absorbance

0.8

0.6

0.4

0.2

0.0
400

500

600

700

800

900

1000

1100

Wavelength (nm)
Figure 37: Normalized spectral profile of AuNPs synthesized using DiaSynth
method in a 12000 Da MWCO Dialysis membrane, using 11 mL of 2 mM
HAuCl4 and various amount of 3 mM Na2S2O3 (2.5, 3, and 3.5 mL).

Samples nIR Wavelength Peak (nm) Quality Ratio
2.5 mL

746

1.904

3 mL

760

1.458

3.5 mL

763

1.199

Table 14: nIR peak and the quality ratios of each sample from Figure 38.
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Samples

2.5 mL

3 mL

3.5 mL

Size (nm)

40.12

43.12

42.19

Zeta Potential (mV)

-32.6

-35.675

-38.75

Table 15: Size and zeta measurements of the samples.
2.4.14.3

Conclusion
Instead of running the dialysis for 1 hr, it was accidently left running for

1.5 hrs. From the given data (Figure 38 & Table 14), the sample with 11 mL of 2
mM HAuCl4 mixed with 2.5 mL of 3 mM Na2S2O3 in a 12000 Da MWCO
Dialysis membrane, dialyzed against DI water, has the best nIR RnIR/Au = 1.9;
while the other samples with 3 and 3.5 mL of 3 mM Na2S2O3 has a lower RnIR/Au.
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2.4.15 DiaSynth – Dialysate
Using the DiaSynth method, samples are being dialyzed with a known
MWCO dialysis membrane. However, it is unclear if the colloidal nanoparticles
are forming on the outside or whether they get dialyzed out. The purpose of this
experiment is to synthesize a bath of AuNPs using the DiaSynth method, and
using rotary evaporator (rotovap) on the dialysate, concentrate the sample down,
and measure the it for further analyze the sample. The purpose of the rotovap is
to gently remove any solvents in the sample, water, by evaporation.
2.4.15.1

Protocol
Fill a 1 L beaker with 800 mL of DI water and place stir bar inside. Next,

in a 12000 Da MWCO Dialysis membrane, a mixture of 11 mL of 2 mM HAuCl4
(first in the bag) and 2.5 mL of 3 mM Na2S2O3 (second after the gold solution
had been added), and let the sample dialyze for 1 hr. Once the dialysis is finished,
removed the dialysate, and rotovap the sample until only 20 mLs of it is left. Then
for a non-dialysis sample, 11 mL of 2 mM HAuCl4 and 2.5 mL of 3 mM
Na2S2O3 is mixed in a 50 mL tubes and reacted for 1 hr. Next, spectral scans
were obtained after an hour of the self-assembly synthesis at room temperature
(RT), using a UV/Vis spectrophotometer (Carey 50 Varian). A Malvern Zetasizer
(ZS90) and TEM (FEI Tecnai F20) were used to characterize the GGS
nanoparticles surface charge, size, and morphology.
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Figure 38: Normalized spectral profile of Non-Dialyzed, 12000 Da MWCO
Dialysis membrane, and the rotovap sample.
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(A)

(B)

(C)

(D)

Figure 40: (A) & (B) are the rotovap sample, while (C) & (D) are the 12000
Da MWCO Dialysis product samples.
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Sample

NonDialysis

12000 Da MWCO
Dialysis

Dialysate Rotovap
Sample

Size (nm)

~ 40

~40

2, 78, 188, & 500+

Zeta
(mV)

- 38

- 33

- 23

Peak
(nm)

-

811

530

Ratio

-

1.9

-

Table 16: nIR spectral peak, quality ratio, size, and zeta measurements of the
samples, a detailed explanation is given in the conclusion section.
2.4.15.3

Conclusion
Using the DiaSynth method, AuNPs have been synthesized at a high

purity. From this experiment, a 12000 Da MWCO Dialysis membrane was used to
mix 11 mL of 2 mM HAuCl4 with 2.5 mL of 3 mM Na2S2O3. Once the dialysis
is finished, the dialysate was removed and rotovapped until only 20 mLs of it is
left. From Table 11, in the Dialysate Rotovap sample, there are multiple sized
particles; this could be due to the fact that particles colliding and forming large
aggregations (Figure 39). Next, the Dialysate Rotovap sample has an absorbance
peak at 530 nm, which is the same peak as the colloidal particles mentioned in the
Introduction section. This confirms that the colloidal particles are indeed
dialyzing out of the back and forcing ion exchange, which the ultimately effects
the quality ratio to form the nIR favoring particles.
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2.4.16 DiaSynth – Scale up
Using the DiaSynth method, AuNPs have been synthesized at a high
purity; however from a manufacturing standpoint, the process must be able to
scale up in order to create a large bath of AuNPs with high purity and minimal
processing. This experiment focuses on synthesizing AuNPs with the DiaSynth
method with double the volume.
2.4.16.1

Protocol
Fill an 8 L bucket with 7.5 – 8 L of DI water and place stir bar inside.

Next, in a 12000 Da MWCO Dialysis membrane, a mixture of 22 mL of 2 mM
HAuCl4 (first in the bag) and 5 mL of 3 mM Na2S2O3 (second after the gold
solution had been added), and let the sample dialyze for 1. The experiment was
repeated, except a mixture of 44 mL of 2 mM HAuCl4 (first in the bag) and 10
mL of 3 mM Na2S2O3 (second after the gold solution had been added), and
sample being dialyzed for 2 hrs (explained in the conclusion of this section).
Next, spectral scans were obtained after an hour of the self-assembly synthesis at
room temperature (RT), using a UV/Vis spectrophotometer (Carey 50 Varian). A
Malvern Zetasizer (ZS90) and TEM (FEI Tecnai F20) were used to characterize
the GGS nanoparticles surface charge, size, and morphology.
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Figure 39: Normalized spectral profile of the two different scale ups.

Sample

Peak (nm)

Ratio

Size Zeta
(nm) (mV)

22 + 5 (1 hr)

766

1.92

42.1 -35.9

44 + 10 (1 hr)

988

2.25

42.7 -37.3

44 + 10 (2 hr)

818

2.38

41

-37.8

Table 17: nIR spectral peak ,quality ratio, size, and zeta measurements of the scale
up samples.
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(A)

(B)

(C)

(D)

(E)

(F)

Figure 40: (A), (B), and (C) are non-dialyzed samples, while (D), (E), and (F) are from the 44+10 scale up.
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2.4.16.3

Conclusion
Using the DiaSynth method, AuNPs has been synthesized at a high purity, as

mentioned and reported previously. From this experiment, a 12000 Da MWCO
Dialysis membrane was used to mix 22 mL of 2 mM HAuCl4 with 5 mL of 3 mM
Na2S2O3, and a mix 44 mL of 2 mM HAuCl4 with 10 mL of 3 mM Na2S2O3.
Once the dialysis is finished, spectral profile, size, zeta, and TEM measurements
were taking. For the 44+10 sample, the experiment reported here is the same as 1 hr
test, on that one 2 hrs was not an option. The 44+11 samples shows little to no
colloidal formation (see Figure 42).

3

CHAPTER 3 - DISCUSSION AND CONCLUSION
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3.1 AuNPs
Gold nanoparticles (AuNPs) has attracted enormous attention in the field of
nanotechnology for applications such as, immunoassays, drug delivery, contrast
enhancement, ex/in-vivo imaging, in-vitro assays, and cancer therapy (theranostic
applications) (Section 1.2). These nanoparticles have a large surface-to-volume ratio;
not only does this give a possibility of interaction between the gold nanoparticles and
biomolecules, but opens the field to various medical applications. Specifically,
gold/gold sulfide (GGS) nanoparticles have been introduced for many applications in
addition to gold nanoshells and nanorods, for their smaller size, higher absorptive
properties, and ease of fabrication. Theranostic applications have emerged as a
technique to combine diagnosis, treatment, and imaging in cancer research. The ideal
theranostic approach for cancer therapy has several tunable factors, mostly imaging and
treatment, with a display of specifically targeting cancer cells.
In order to use GGS nanoparticles for therapeutic applications, the smaller goldcolloid contaminants formed during the self-assembly process must be removed.
Traditionally, colloidal gold particles are removed via multi-step (3X) centrifugation
(Section 2.2 & 2.4.1), which is not only time consuming but inefficient. The removal of
colloidal gold will reduce the total number of particles delivered to the body and reduce
the impact on the reticulo-endothelial system (RES). Once the GGS particles have been
synthesized, using 2 mM HAuCl4*3H2O and 3 mM Na2S2O3, they undergo a
multistep centrifugation, Figure 4 shows the spectra of the samples, “as made” and after
“3X centrifugation”. There is a significant increase in the quality ratio, as seen in Figure
4, for the “as made” product the RnIR/Au = 0.83; while the particles after multi-step
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centrifugation has an RnIR/Au = 1.95, as expected the RnIR/Au is increased due to the
removal of the colloidal nanoparticles.
The use of Na2S2O3 as an alternative to Na2S has allowed a robust process to be
developed where the nIR absorbing peak can be precisely controlled. By varying the
volumes of reactants, this nIR peak can be reproduced time and again with great
accuracy and precision (+/- 5 nm), in direct contrast with the method used where the
aging of Na2S had to be within a precise range, and still resulted in particles with nIR
peaks that could vary as much as +/- 50 nm each time. In addition, the centrifugation
process selects various components of the population, thus resulting in a shift of the
peak absorbance wavelength of the final product may be away from the desired peak for
the application. Detailed analysis of the dialysate and product is performed to
understand the exact mechanism leading to increased yields, high quality ratio.
However, this process represents a dramatic shift in production and scale up strategy,
which could enable wider use of these nIR absorbing particles in a variety of
applications.

3.2 Temperature Effects
From basic chemistry, the chemical kinetics deals with reaction rates; and the
reaction rates is contributed by concentration of reactants, physical state of the reactants,
temperature at which the reaction takes occurs, and the use of a catalyst. Under a
“given” set of conditions, each reaction has its own rate, but can be influenced. For this
thesis two main influencing factors were used: concentration and temperature. The
concentration of the sample can affect the frequency of the collisions between reactant
molecules; in this case it is 2 mM HAuCl4 and 3 mM Na2S2O3. The temperature can
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affect the rate by two factors: (1) influencing the frequency and, (2) the energy of the
reactant collision.
By adding in these conditions, change in temperature and concentration, prior to
or during the synthesis of the AuNPs, the equilibrium has shift to favor the formation of
nIR particles and the quality ratio in several experiments was greater than 1.6. However,
this ratio was not close to the multi-step centrifugation method. In order to use these
particles or therapeutic applications it is essential to increase the quality ratio to 2 or
higher. Other experiments, not reported here, were also done including a modification of
the two-step method. The two-step method reported by Zhou et al was modified, instead
of adding in the Na2S2O3 as the secondary addition, the gold solution was added to
“coat” or for a “shell” on to the GGS particles that are forming. This also resulted in
RnIR/Au > 1.5, but less than 1.8.
3.3 DiaSynth
Using dialysis during the production of GGS nanoparticles not only forcing ionexchange (by removing reactants or products), but as a consequence the equilibrium of
the reaction can be shifted to favor the formation of nIR absorbing particles within the
dialysis tubing and formation of gold colloid outside. Several dialysis MWCO
membranes were used including: 2KDa, 3.5KDa, 6-8KDa, and 12KDa, samples were
then reacted for 1 hr in 8 L of DI water at RT. From the spectral profile, given in Figure
37, dialysis with a 12KDa MWCO dialysis membrane shows the highest quality ratio.
Next, the experiment was repeated using a 12 MWCO dialysis membrane, varying the
amount of Na2S2O3 added. As evidenced in Figure 38 & Table 14, using the 2.5 mL of
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Na2S2O3, further improved the quality ratio. The experiment was repeated using only the
2.5 mL of Na2S2O3 for statistical analysis.
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Figure 41: Spectral profile of GGS nanoparticles synthesized using the ratio
11+2.5, the experiment was repeated with n = 5.
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Sample

11+2.5

nIR Wavelength Peak
(nm)

Quality Ratio

Size (nm)

Zeta (mV)

802

1.88

33.72

-35.9

805

2.00

33.46

-33.8

785

1.84

32.98

-34.4

814

1.88

34.23

-34.4

858

1.81

34.38

-35.3

Table 18: nIR spectral peak, quality ratio, size, and zeta measurements of sample from
Figure 41. The average nIR peak is 813 nm ± 27 nm, and the average quality ratio is
1.88 nm ± 0.07.
These results indicate the larger pore sizes of the membrane facilitate the
diffusion and removal of certain species, during the reaction, which favors the
production of nIR absorbing particles within the membrane. Additionally, increasing
HAuCl4/Na2S2O3 ratio shows an increase in purity at a fixed pore size. To allow
formation of high ratio nIR absorbing nanoparticles compared to gold colloid which are
a contaminant, in the DiaSynth process samples are dialyzed during the reaction. By
dialyzing the samples, it allows us to change the kinetics and therefore shifting the
equilibrium of the reaction. Our assumptions are based on the following system
equations (2) and (4) shown above. Dialyzing samples at various time points we are
having ions exchanging, which allows us to control the bandwidth and peak of the
particles, ultimately help reduce the colloids and remove ions from the solution. This
effect significantly decreases the gold colloid production, giving us a higher ratio of
AuNPS nanoparticles compared to colloidal gold. The order to compare the over yield
of the scale up process, a batch close to the nIR peak with the same volume was made
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(Table 19). From Table 19, DiaSynth (left side) are GGS particles as made, while the
right side is the particles as made and with multi-step centrifugation.
DiaSynth

Non-Dialysis

As made

7.5 OD, 55 mLs

2.5 OD, 55 mLs

After multistep centrifugation

-

117 OD, .340 mL

Final Yield

412.5

28.9

Quality Ratio

2.36

2.38

Table 19: Results from the Non-Dialysis and DiaSynth method.
The results show that DiaSynth method has a significantly higher final yield ( 7.5 OD x 55
mL, compared to 117 OD x 0.34 mL) than as made GGS particles after multistep
centrifugation. In the end, the DiaSynth method as proven to be an effective method on
synthesizing nIR particles with little to no modification in the GGS synthesis compared to
as made GGS particles and doing a multi-step centrifugation.
3.4 Future Direction
The use of AuNPs in biomedical field has endless applications. Using the DiaSynth
method, quality of nIR GGS particles has improved tremendously. It is not clear whether
the particles formed using the DiaSynth method and the RT method are the same “species”
being formed. Both syntheses allow the formation of the nIR GGS nanoparticles; further
characterization of the both types of synthesis is required.
To clarify the reaction mechanism a technique known as x-ray photoelectron
spectroscopy can be used to understand the oxidization states of the HAuCl4 and Na2S2O3
and compared to as made product. Other techniques are also recommended such as X-ray
diffraction patterning to understand the final products of the synthesis; furthermore, for
detailed characterization Inductively coupled plasma mass spectrometry (ICPMS)
and Energy-dispersive X-ray spectroscopy (EDAX).
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Lastly, further scaling up the DiaSynth is very important, not only from the
manufacturing perspective but from a medical stand point as well. The GGS particles
formed must be synthesized for large clinical studies and/or any other application that
require a large batch of particles. Future scale up models should consider with using an
automated process and larger volumes. A provisional patent has been filed on the DiaSynth
process on the unique process, not only is the DiaSynth process more efficient but has a
higher yield than current processes. Furthermore, this process may be applicable to other
types of self-assembled one-pot synthesis procedures such as quantum dots if the correct
membranes and temperature regimes are adhered.
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BACKGROUND OF THE INVENTION
(a) Field of the Invention
[0001]

Embodiments disclosed herein relate to a method for synthesizing self-

assembling nanoparticles with defined plasmon resonances. More particularly, certain
embodiments disclosed herein relate to an improved method for synthesizing selfassembling gold / gold sulfide nanoparticles by dialyzing samples during the self-assembly
process.

(b) Description of the Prior Art
[0002]

U.S. Application Nos. 12/807,792 and 12/807,793, incorporated herein by

reference in their entireties, disclose gold / gold sulfide (“GGS”) nanoparticles within a
chitosan matrix, and methods for synthesizing and using the same. These references
disclose forming GGS nanoparticles by self-assembly of a sulfide source, such as sodium
thiosulfate, and a gold source, such as cholorauric acid. GGS nanoparticles have
absorbance peaks in the near infra-red (“NIR”) region, which are tunable by varying the
self-assembly conditions. During self-assembly of GGS nanoparticles, gold colloid is
simultaneously formed as a byproduct.

SUMMARY OF THE INVENTION
[0003]

Embodiments disclosed herein relate to a method for synthesizing self-

assembling nanoparticles. More particularly, certain embodiments disclosed herein relate to
an improved method for synthesizing self-assembling GGS nanoparticles by dialyzing
samples during the self-assembly process. In some embodiments, an improved method for
synthesizing GGS nanoparticles disclosed herein provides a higher ratio of GGS
nanoparticles to gold colloid as compared to the method cited in U.S. Application Nos.
12/807,792 and 12/807,793.
[0004]

In one embodiment, a method for synthesizing nanoparticles comprises

blending gold source and a sulfide source within a first chamber, the first chamber being
separated from a second chamber by a dialysis membrane.
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[0005]

This summary is provided to introduce a selection of the concepts that are

described in further detail in the detailed description and drawings contained herein. This
summary is not intended to identify any primary or essential features of the claimed subject
matter. Each embodiment described herein is not intended to address every object
described herein, and each embodiment does not necessarily include each feature described.
Other forms, embodiments, objects, advantages, benefits, features, and aspects of the
present invention will become apparent to one of skill in the art from the detailed
description and drawings contained herein.

BRIEF DESCRIPTION OF THE DRAWINGS
[0006]

A better understanding of the present invention will be had upon reference to

the following description in conjunction with the accompanying drawings, wherein:
[0007]

Fig. 1 is a TEM image of a sample including GGS nanoparticles and gold

colloid;
[0008]

Fig. 2 is a TEM image of a sample including GGS nanoparticles;

[0009]

Fig. 3 is an image showing the spectra scan of samples from Example 1;

[0010]

Fig. 4 is an image showing the spectra scan of samples from Example 2;

[0011]

Figs. 5A-5B are images showing the spectra scan of samples from Example

3;
[0012]

Fig. 6 is an image showing the spectra scan of samples from Example 4;

[0013]

Fig. 7 is an image showing the spectra scan of samples from Example 5;

[0014]

Figs. 8A-8C are images showing spectra of samples from Example 6;

[0015]

Fig. 9 is an image showing the spectra scan of samples from Example 7;

[0016]

Fig. 10 is an image showing the spectra scan of samples from Example 8;

[0017]

Figs. 11A-11B are images showing spectra of samples from Example 9;

[0018]

Fig. 12 is an image showing the spectra scan of samples from Example 10;

and
119

[0019]

Figs. 13A-B are images showing spectra of samples from Example 11, and

Figs. 13C-D are charts showing the relationship between peak wavelength and Int ratio
(defined below), and between quality ratio and Int ratio.

DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENT
[0020]

For purposes of promoting an understanding of the principles of the

invention, reference will now be made to one or more selected embodiments illustrated in
the drawings and specific language will be used to describe the same. It will nevertheless
be understood that no limitation of the scope of the invention is thereby intended; any
alterations and further modifications of the described or illustrated embodiments, and any
further applications of the principles of the invention as illustrated herein are contemplated
as would normally occur to one skilled in the art to which the invention relates. One
embodiment of the invention is shown in great detail, although it will be apparent to those
skilled in the relevant art that some features or some combinations of features may not be
shown for the sake of clarity.
[0021]

GGS nanoparticles are preferably created by the self-assembly of a sulfide

source and a gold source. In some embodiments, the sulfide source is a sulfide salt. In
certain embodiments, the sulfide source is sodium thiosulfate (Na2S2O3), sodium sulfide
(Na2S), or other suitable sulfur-containing chemical or mixture of chemicals. In some
embodiments, the gold source is a gold salt. In some embodiments, the gold source is
chloroauric acid (HAuCl4), sodium tetrachloroaurate(III) dehydrate (NaAuCl4), or other
suitable gold-containing chemical or mixture of chemicals. The absorbance peak of GGS
nanoparticles can be controlled by cooperatively adjusting the ratio of sodium thiolsulfate
and chloroauric acid solutions used to create the GGS nanoparticles. In addition, the
concentration of each component may also affect the absorbance peak. Using
manufacturing methods disclosed herein, stable GGS nanoparticles may be produced with
absorbance peaks between about 600 nm and about 1000 nm. In certain embodiments, GGS
nanoparticles are selectively manufactured to have an absorbance peak substantially
identical to the wavelength of the laser used to excite the GGS nanoparticles to maximize
the energy absorbed by the GGS nanoparticles.
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[0022]

Referring now to Fig. 1, gold colloid is a byproduct of GGS nanoparticle

self-assembly. Gold colloid has an absorbance peak at 530 +/- 20 nm. In the methods
disclosed in the referenced applications, gold colloid is removed through centrifugation.
GGS nanoparticles are separated from gold colloid by centrifugation. An example
separation process is centrifugation at 1000 g for 20 minutes. Additional centrifugation
steps may be used to increase purity.
[0023]

Referring now to Fig. 2, GGS nanoparticles are formed in a several shapes,

including rods, generally triangular plates, and generally spherical bodies. The term “GGS
nanoparticles” is not shape specific and includes particles of particular shapes and mixtures
of shapes. The shape of individual GGS nanoparticles within a sample affects the overall
absorbance spectrum of the sample. Rod-shaped particles, when oriented on end, provide
an absorbance peak at about 530 nm. Therefore, even when substantially all gold colloid is
removed from a sample, a measure of absorbance at about 530 nm may still be present.
[0024]

In some embodiments, a sample contains a gold source and a sulfide source

which self-assemble into GGS nanoparticles and gold colloid. The sample is dialyzed
against deionized (“DI”) water during the self-assembly process. In certain embodiments,
the gold source and sulfide source are blended in a bag-shaped dialysis membrane. In other
embodiments, the gold source and sulfide source are blended together for a specific length
of time then transferred into a bag-shaped dialysis membrane. In certain embodiments, the
gold source and sulfide source are blended in a first chamber, the first chamber being
separate from a second chamber by a dialysis membrane. In certain embodiments, the
second chamber may be a re-circulating or purged flow water bath. In certain
embodiments, the first chamber may be a flow-through dialysis cell.
[0025]

As shown in the examples below, variation in the dialysis time, the

molecular weight cut off (“MWCO”) of the dialysis membrane, and the ratio of gold source
to sulfide source modifies the quality ratio of the resulting product and the wavelength of
the absorbance peak. Without being bound by theory, it is hypothesized that dialysis
performed during the self-assembly process forces ion-exchange across the membrane,
providing a change in reaction kinetics. This hypothesized change in kinetics results in a
shift in the equilibrium of the self-assembly reaction which favors GGS nanoparticle
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production within the dialysis membrane and gold colloid production outside the
membrane.
[0026]

A “quality ratio” is the ratio of the absorbance of synthesized particles in the

NIR region (700 nm to 900 nm, for the purposes of this calculation), which corresponds to
absorbance characteristics of GGS nanoparticles, relative to absorbance at 530 +/- 20 nm,
which corresponds to the absorbance characteristics of gold colloid. Earlier GGS synthesis
methods provided quality ratios in the range of 0.4 – 0.8 prior to any separation steps, such
as centrifugation. The method disclosed herein has provided quality ratios above 1.8, above
2.0, and above 2.3, prior to separation steps, indicating a significantly higher yield of GGS
nanoparticles.
[0027]

The examples herein disclose the use of dialysis membranes to improve the

yield of self-assembled GGS nanoparticles. However, dialysis membranes may be used to
improve the yield of other self-assembling nanoparticles as well. In further embodiments, a
first chemical species and a second chemical species are blended in a first chamber, the first
chamber being separated from a second chamber by a dialysis membrane, wherein the first
chemical species and the second chemical species self-assemble into a nanoparticle. In
certain embodiments, the first chemical species is a gold source and the second chemical
species is a sulfide source. In other embodiments, the first chemical species is a silver
source and the second chemical species is a nitride source. In some embodiments, the first
chamber is a dialysis membrane shaped to form a bag and the second chamber is a liquidfilled beaker, vial, vat, bucket, or other container in which the first chamber is submerged.
In other embodiments, a first chemical species may be dialyzed against the second chemical
species to form self-assembling nanoparticles. In these embodiments, a first chemical
species is added into a first chamber and a second chemical species is added into a second
chamber, the first chamber and second chamber being separated by a dialysis membrane.
[0028]

The following examples are provided to illustrate certain specific features of

working embodiments and general protocols. The scope of the present invention is not
limited to those features exemplified by the following examples. Spectral scans disclosed in
the examples were obtained using a UV/Vis spectrophotometer (Carey 50 Varian), and all
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disclosed wavelengths are in nanometer units. Nanometer-scale images were obtained
using a tunneling electron microscope (“TEM”) (200 kV FEI Tecnai F20).
EXAMPLE 1
[0029]

Fill a 1 L beaker with 800 mL of DI water and include a stir bar. Add a

mixture of 11 mL of 2 mM HAuCl4 and 3 mL of 3 mM Na2S2O3 in a 3500 Molecular
Weight Cut Off (“MWCO”) dialysis membrane for 1 hour (sample 1). For a non-dialysis
control sample, 11 mL of 2 mM HAuCl4 and 3 mL of 3 mM Na2S2O3 are mixed in a 50 mL
tube and reacted for 1 hour (sample 2). Fill a second 1L beaker with 3 mM Na2S2O3. Add
25 mL of 2 mM HAuCl4 in a 3500 MWCO dialysis membrane to the second beaker and let
it react for 1 hour (sample 3).
[0030]

Spectral scans of the samples are shown in Fig 3. Sample 1 has a peak at

attributable to gold colloid and a strong, distinct peak in the NIR range attributable to GGS
nanoparticles. Sample 2 has a peak attributable to gold colloid and strong absorbance NIR
range and extending into longer wavelengths. Sample 3 has a peak absorbance at about 530
nm and no peak in the 700 – 900 nm range, indicating the formation only of gold colloid.
EXAMPLE 2
[0031]

Fill a 1 L beaker with 800 mL of DI water and include a stir bar. Add a

mixture of 11 mL of 2 mM HAuCl4 and 3 mL of 3 mM Na2S2O3 in a 3500 MWCO dialysis
membrane to the beaker for 1 hour (sample 1). For a non-dialysis sample (sample 2), 11
mL of 2 mM HAuCl4 and 3 mL of 3 mM Na2S2O3 are mixed in a 50 mL tube and reacted
for 1 hour. Separately, fill two 1L beakers with 3 mM Na2S2O3. To each beaker, add 25
mL of 2 mM HAuCl4 in a 3500 MWCO dialysis membrane and let them react for 2.5 and 5
hours, respectively.
[0032]

Spectral scans of the samples are shown in Fig. 4. As shown, samples 3 and

4 have negligible GGS nanoparticle formation.
EXAMPLE 3
[0033]

Fill four 1 L beakers with 800 mL of DI water and stir bar. Place a mixture

of 11 mL of 2 mM HAuCl4 and 2 mL of 3 mM Na2S2O3 in a 3500 MWCO dialysis
membrane into two beakers for 1 and 2 hours, respectively (samples 2 and 3 of Fig. 5A).
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Place a mixture of 11 mL of 2 mM HAuCl4 and 3 mL of 3 mM Na2S2O3 in a 3500 MWCO
dialysis membrane into two beakers for 1 and 2 hours (samples 2 and 3 of Fig. 5B). For a
non-dialysis sample (sample 1 of Figs. 5A and 5B), 11 mL of 2 mM HAuCl4 and 2 or 3 mL
of 3 mM Na2S2O3 are mixed in a 50 mL tube and reacted for 1 hr.
[0034]

Spectral scans of the samples are shown in Figs. 5A and 5B. As shown, the

sample of 11 mL of 2 mM HAuCl4 and 2 mL of 3 mM Na2S2O3 dialyzed in a 3500 MWCO
dialysis membrane produces the largest peak shift in the NIR range.
EXAMPLE 4
[0035]

Fill two 1 L beakers with 800 mL of DI water and stir bar. Maintain a water

temperature of about 100°C. Add a mixture of 11 mL of 2 mM HAuCl4 and 3 of 3 mM
Na2S2O3 in a 3500 MWCO dialysis membrane for a 5 minute soak (sample 1). Add a
mixture of 11 mL of 2 mM HAuCl4 and 2 mL of 3 mM Na2S2O3 in a 3500 MWCO dialysis
membrane for a 15 minute soak (sample 2).
[0036]

As shown in Fig. 6, neither sample produced a peak in the NIR range.
EXAMPLE 5

[0037]

Fill an 8 L bucket with DI water and stir bar. In a 1-step method, a mixture

of 11 mL of 2 mM HAuCl4 and 3 mL of 3 mM Na2S2O3 in a 3500 MWCO dialysis
membrane is added for 1 hour (sample 2). Next for a 2-step method, 4 mL of 2 mM
HAuCl4 and 3 mL of 3 mM Na2S2O3 are reacted for 30 seconds in a 50 mL tube, then added
into a 3500 MWCO dialysis membrane with an additional 7 mL of 2 mM HAuCl4 to react
for an hour (sample 3). For a non-dialysis sample, 11 mL of 2 mM HAuCl4 and 3 mL of 3
mM Na2S2O3 are mixed in a 50 mL tube and reacted for 1 hour (sample 1).
[0038]

Spectral scans of the samples are shown in Fig. 7. As shown, the two step

method of mixing the gold source and sulfide source shortly before insertion into the
dialysis membrane resulted in a higher quality ratio, but a lower peak shift, than the one step
method.
EXAMPLE 6
[0039]

Fill an 8 L bucket with DI water and stir bar. Combine samples of 11 mL of

2 mM HAuCl4 and 3 mL of 3 mM Na2S2O3 in 3.5 KDa and 12 KDa MWCO dialysis
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membranes, and allow each to react for an hour (samples 2 and 3 of Fig. 8A). For a 2-step
method, react samples of 4 mL of 2 mM HAuCl4 and 3 mL of 3 mM Na2S2O3 for 30
seconds, then add 7 mL of 2 mM HAuCl4 and place in 3.5 and 12 KDa MWCO dialysis
membranes to allow further reaction for an hour (samples 2 and 3 of Fig. 8B). For a nondialysis sample, 11 mL of 2 mM HAuCl4 and 3 mL of 3 mM Na2S2O3 are mixed in a 50 mL
tube and reacted for 1 hour (sample 1 of Figs. 8A, 8B and 8C). Additionally, the following
controls were also synthesized: 2-step, react samples of 4 mL of 2 mM HAuCl4 and 3 mL of
3 mM Na2S2O3 for 30 seconds, then add 7 mL of 2 mM HAuCl4 and allow to react for 1
hour (sample 2 of Fig. 8C); 1-step dialysis as above using a 12 KDa MWCO dialysis
membrane (sample 3 of Fig. 8C); and 2-step dialysis as above using a 12 KDa MWCO
dialysis membrane (sample 4 of Fig. 8C).
[0040]

Spectral scans of the samples are shown in Figs. 8A – 8C. In both the 1-step

process and 2-step process, dialysis provides a greatly increased quality ratio as compared
to the non-dialysis sample, as shown by the relatively small gold colloid peaks. For the 1step process, Fig. 8A shows that using the 3.5 KDa MWCO dialysis membrane results in a
greater peak shift and a higher quality ratio than the 12 KDa MWCO dialysis membrane. In
contrast, Fig. 8B shows that using a 3500 MWCO dialysis membrane results in the NIR
absorbance peak shifting to a higher wavelength than the non-dialysis sample for the 2-step
process. Fig. 8C shows that the two step process, used without dialysis, does not produce a
significant fraction of NIR GGS nanoparticles.
EXAMPLE 7
[0041]

Fill two 1 L beakers with 800 mL of DI water and stir bar. Maintain a water

temperature of 65° C in one of the beakers, while the other is left at room temperature (RT).
Add a mixture of 11 mL of 2 mM HAuCl4 and 3 mL of 3 mM Na2S2O3 in a 3500 MWCO
dialysis membrane to the RT beaker (sample 2) and the 65° C beaker (sample 3), each for 1
hour. For a non-dialysis sample, 11 mL of 2 mM HAuCl4 and 3 mL of 3 mM Na2S2O3 are
mixed in a 50 mL tube and reacted for 1 hour (sample 1).
[0042]

Spectral scans of the samples are shown in Fig. 9. As shown, the yield of

GGS nanoparticles, as evidenced by the NIR peak, was significantly greater at RT than at
the elevated temperature.
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EXAMPLE 8
[0043]

Fill an 8 L bucket with DI water and stir bar. Add a mixture of 11 mL of 2

mM HAuCl4 and 3 mL of 3 mM Na2S2O3 in 2 KDa and 3 KDa MWCO dialysis membranes
for 1 hour (samples 2 and 3). For a non-dialysis sample, 11 mL of 2 mM HAuCl4 and 3 mL
of 3 mM Na2S2O3 are mixed in a 50 mL tube and reacted for 1 hour (sample 1).
[0044]

Spectral scans of the samples are shown in Fig. 10. As shown, use of the

3.5 KDa MWCO dialysis membrane provides a significantly larger NIR peak shifts than the
2 KDa MWCO membrane. The following Table 1 is a summary of the absorbance peaks
and quality ratios for each sample.
Table 1.
Samples
Sample 1 / No dialysis
Sample 2 / 2 KDa MWCO
Sample 3 / 3.5 MWCO

Summary of Sample Properties in Example 8
NIR Absorbance Peak (nm)
928
918
765

Quality Ratio
1.473
1.378
1.513

EXAMPLE 9
[0045]

Fill an 8 L bucket with DI water and stir bar. Add mixtures of 11 mL of 2

mM HAuCl4 and 3 mL of 3 mM Na2S2O3 in three separate 3.5 KDa MWCO dialysis
membranes for 1, 2, and 4 hour, respectively (samples 2, 3, and 4 of Fig. 11A). Fill a
separate 8 L bucket with DI water and stir bar. Add mixtures of 11 mL of 2 mM HAuCl4
and 3 mL of 3 mM Na2S2O3 in three separate 2 KDa MWCO dialysis membranes for 1, 2,
and 4 hours, respectively (samples 2, 3, and 4 of Fig. 11B). For a non-dialysis sample, 11
mL of 2 mM HAuCl4 and 3 mL of 3 mM Na2S2O3 are mixed in a 50 mL tube and reacted
for 1 hour (sample 1 of Figs. 11A and 11B). Spectral scans of the samples are shown in
Figs. 11A and 11B.
[0046]

The following Table 2 is a summary of the absorbance peaks, extinction

coefficients, and quality ratios of each sample. For the non-dialyzed “No Dia” control
samples, the column “Dialysis Time” simply indicates the delay between mixing the gold
and sulfide sources and acquiring the spectral data.
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Table 2.
Samples

No Dia
(sample 1, Figs.
11A and 11B)
2K Dia
(sample 2, Fig.
11B)
2K Dia
(sample 3, Fig.
11B)
2K Dia
(sample 4, Fig.
11B)
3.5K Dia
(sample 2, Fig.
11A)
3.5K Dia
(sample 3, Fig.
11A)
3.5K Dia
(sample 4, Fig.
11A)

Summary of Sample Properties in Example 9

Dialysis
Time
(hours)
1

NIR
Absorbance
Peak (nm)
959

Colloid
Extinction
Coeff.
0.766

NIR
Extinction
Coeff.
1.179

Quality
Ratio

1

899

0.605

0.821

1.357

2

926

0.632

0.895

1.416

4

930

0.616

0.889

1.444

1

816

0.599

0.916

1.527

2

815

0.622

1.007

1.620

4

819

0.615

0.967

1.573

1.539

EXAMPLE 10
[0047]

Fill an 8 L bucket with DI water and stir bar. Add mixtures of 11 mL of 2

mM HAuCl4 and 2 mL of 3 mM Na2S2O3 in three separate 3.5 KDa MWCO dialysis
membranes for 1, 2, and 4 hour, respectively. Also, add mixtures of 11 mL of 2 mM
HAuCl4 and 2 mL of 3 mM Na2S2O3 in three separate 2 KDa MWCO dialysis membranes
for 1, 2, and 4 hours. For a non-dialysis sample, 11 mL of 2 mM HAuCl4 and 2 mL of 3
mM Na2S2O3 are mixed in a 50 mL tube and reacted for 1 hour.
[0048]

Spectral scans of the samples are shown in Fig. 12. As shown, dialysis using

3.5 KDa MWCO dialysis membranes produced significant peak shifts. Dialysis using 2
KDa MWCO dialysis membranes did not result in distinct peaks in the NIR range..
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EXAMPLE 11
[0049]

Fill an 8 L bucket with DI water and stir bar. Add mixtures of 11 mL of 2

mM HAuCl4 and 2.5, 3, 3.5, 4, 4.5, or 5 mL of 3 mM Na2S2O3 in 50 mL tubes, or 2 KDa or
3.5 KDa MWCO dialysis membranes for 1 hour. The following Table 3 is a summary of
the samples, their Int ratios, NIR peaks, and quality ratios. An “Int ratio” is the ratio of the
volume of gold source to the volume of sulfide source in a given sample, the concentrations
of the gold source and sulfide source remaining constant between compared samples. For
example, 11 mL of 2 mM HAuCl4 and 2.5 mL of 3 mM Na2S2O3 provides an Int ratio of 11
/ 2.5 = 4.40. Non-dialyzed samples are identified herein as “RT” or room temperature,
although all samples were maintained at room temperature throughout the experiment.
Table 3.
Dialysis
Method
RT
RT
RT
RT
RT
RT
2 KDa
2 KDa
2 KDa
2 KDa
2 KDa
2 KDa
3.5 KDa
3.5 KDa
3.5 KDa
3.5 KDa
3.5 KDa
3.5 KDa
[0050]

Summary of Sample Properties in Example 11

Sample (vol. gold source +
vol. sulfide source)
11+2.5
11+3
11+3.5
11+4
11+4.5
11+5
11+2.5
11+3
11+3.5
11+4
11+4.5
11+5
11+2.5
11+3
11+3.5
11+4
11+4.5
11+5

Int Ratio
4.40
3.67
3.14
2.75
2.44
2.20
4.40
3.67
3.14
2.75
2.44
2.20
4.40
3.67
3.14
2.75
2.44
2.20

NIR Absorbance
Peak (nm)
none
995
901
852
807
779
931
928
950
848
771
771
789
816
820
834
789
747

Quality Ratio
N/A
1.675
1.398
1.126
0.895
0.730
1.588
1.421
1.436
1.209
0.783
0.787
1.804
1.731
1.621
1.352
1.038
0.787

Spectral scans of selected samples from Table 3 are shown in Figs. 13A and

13B. More specifically, Fig. 13A includes spectral scans of samples dialyzed in 2 KDa
MWCO dialysis membranes and Fig. 13B includes spectral scans of samples dialyzed in 3.5
KDa MWCO dialysis membranes. Fig. 13C depicts the correlation between NIR peak
wavelength and Int ratio. Fig. 13D depicts the correlation between quality ratio and Int
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ratio. Note that in several places in Figs. 13C and 13D, a diamond symbol identifying a
non-dialyzed sample is not visible as it is covered by a square symbol identifying a sample
dialyzed in a 2 KDa MWCO dialysis membrane. Fig. 13C indicates that decreasing Int
ratios generally correlate with NIR absorbance peaks at lower wavelengths. As shown in
Fig. 13D, increasing Int ratios generally correlate with increasing quality ratios.
[0051]

The foregoing detailed description is given primarily for clearness of

understanding and no unnecessary limitations are to be understood therefrom for
modifications can be made by those skilled in the art upon reading this disclosure and may
be made without departing from the spirit of the invention.
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ABSTRACT OF THE DISCLOSURE
Embodiments disclosed herein relate to a method for synthesizing self-assembling
nanoparticles with defined plasmon resonances. More particularly, certain embodiments
disclosed herein relate to an improved method for synthesizing self-assembling gold / gold
sulfide nanoparticles by dialyzing samples during the self-assembly process.
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APPENDIX II
APPOINTMENT OF MEMBERS OF THE EXAMINATION COMMITTEE
UNIVERSITY OF LOUISVILLE
J. B. SPEED SCHOOL OF ENGINEERING

June 5th, 2012
(Date)
MEMO TO:
FROM:

Academic Affairs Office
J. B. Speed School of Engineering
Andre M. Gobin, Bioengineering
Thesis Director

SUBJECT:

Appointment of Members of the Master of Engineering Examination Committee for
DHRUVINKUMAR PATEL

THROUGH:

Robert S. Keynton

I. CONSTITUENCY OF EXAMINATION COMMITTEE
It is recommended that the following individuals be officially designated as members of the Master of
Engineering Examination Committee of subject M.Eng. candidate. Each of these persons has been
contacted, and has agreed to serve on the Examination Committee (see page 1 for more detail on
constituency of the committee):
(Name, Department)
1. Andre M. Gobin, Bioengineering
Thesis Director
2. Andrea S. Gobin, Bioengineering
Member
3. Stuart J. Williams, Mechanical Engineering
Member
4.
Member
In addition to the foregoing membership of the Examination Committee, it is requested that the following
committee representatives from outside Speed School, each of whom has agreed to serve, be appointed as
Members of the Examination Committee:
1.
External Member
(Name)
(Mailing Address of External Member)
External Member

2.
(Name)
(Mailing Address of External Member)
II. M.ENG. PROJECT DESCRIPTION

A brief description of the proposed M.Eng. Project is as follows:
This project is focused on the scale up of gold-gold sulfide (GGS) nanoparticles with desired near infrared
peak (nIR) that can be used for therapeutic applications. By combining published the current methods for 1step self-assembly and an equilibrium shifting approach, the reaction is shifted to favor the formation of nIR
absorbing particles.

131

APPENDIX II
(continued)

A tentative title (10 words or less) of the proposed M.Eng. Thesis is:
A Novel High Yield Process for Gold Sulfide Nanoparticle Synthesis

(Signature of Thesis Director)
III.APPROVAL BY DEPARTMENT CHAIR
The Thesis Director has conferred with me relative to the investigation, thesis topic and committee
membership of the indicated student, and I concur with the recommendations.

(Signature of Department Chair)

General Instructions:
The student in collaboration with the Thesis Director should prepare this form: original to the Department
Chair, copy retained by the student, and one copy for the Thesis Director's file.
Full-time students must submit the project description and constituency of the Master of Engineering
examination committee according to the specific dates in Appendix I.
Part-time students must submit the project description and constituency of a Master of Engineering
examination committee not later than one calendar year prior to the student's expected date of graduation.

Approval form to be distributed by Department Chair to M.Eng. candidate, thesis director,
committee members, and Academic Affairs Office.
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APPENDIX III
ORAL EXAMINATION REQUEST
UNIVERSITY OF LOUISVILLE
J. B. SPEED SCHOOL OF ENGINEERING
6/5/12
(Date)
MEMO TO:

Academic Affairs Office

FROM:

(Insert name of M.Eng. Thesis Director)

SUBJECT:

M.Eng. Oral Examination and Thesis Defense for (Name of Student)

1.

The oral examination and thesis defense of subject degree candidate will be held on

Tuesday
No. 306 of
2.

(Day of Week),

June 5th, 2012

(Date), at 10:00 AM (Time) in Room

LUTZ HALL (Building).

The title of the M.Eng. Thesis is:

A NOVEL HIGH YIELD PROCESS FOR GOLD SULFIDE NANOPARTICLE
SYNTHESIS VIA SHIFTING EQUILIBRIUM OF SELF-ASSEMBLY REACTION

__________________________________
(Signature of Thesis Director)

THE STUDENT IS RESPONSIBLE FOR DISTRIBUTION OF THESE COPIES
Copies to:
1) Department Chair
Robert S. Keynton
Andre M. Gobin
2) Thesis Director
Andrea S. Gobin
3) Committee Member
Stuart J. Williams
4) Committee Member
5) Committee Member
6) Committee Member
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APPENDIX III
ORAL EXAMINATION REQUEST
UNIVERSITY OF LOUISVILLE
J. B. SPEED SCHOOL OF ENGINEERING
6/5/12
MEMORANDUM TO:
FROM:
SUBJECT:
1.

Academic Affairs Office
(Insert name of Thesis Director)
M.Eng. Oral Examination and Thesis Defense For (Name of Student)

The oral examination and thesis defense of subject degree candidate will be held on

Tuesday
No. 306 of

(Day of Week),

June 5th, 2012

(Date), at 10:00 AM (Time) in Room

LUTZ HALL (Building).

2.

The examination and defense began at 10:00 AM_ (Time) and was concluded at 11:30 AM (Time).

3.

The candidate PASSED the oral examination and thesis defense.

4.

Qualifications or clarifying statements considered to be important by the Thesis Director (Optional):
_
_
_
(Signature of Thesis Director)

Copy to: Department Chair
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